+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 11979

Chapter 11979 contains a list of PDF Full Texts available from EurekaMag.

Grothues, M.; Traeder, W.; Ott, M., 2005:
Draxxin (R) des erste triamilid, ein jahr im praxistest

Cipolli, C.; Bonanni, E.; Maestri, M.; Mazzetti, M.; Murri, L., 2004:
Dream experience during REM and NREM sleep of patients with complex partial seizures

Suzuki, H.; Uchiyama, M.; Tagaya, H.; Ozaki, A.; Kuriyama, K.; Aritake, S.; Shibui, K.; Tan, X.; Kamei, Y.; Kuga, R., 2004:
Dreaming during non-rapid eye movement sleep in the absence of prior rapid eye movement sleep

Aoki, C.; Sekino, Y.; Hanamura, K.; Fujisawa, S.; Mahadomrongkul, V.; Ren, Y.; Shirao, T., 2005:
Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses

Chew, C.S.; Okamoto, C.T.; Chen, X.; Thomas, R., 2005:
Drebrin E2 is differentially expressed and phosphorylated in parietal cells in the gastric mucosa

Butkevich, E.; Hülsmann, S.; Wenzel, D.; Shirao, T.; Duden, R.; Majoul, I., 2004:
Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton

Peitsch, W.K.; Hofmann, I.; Bulkescher, J.; Hergt, M.; Spring, H.; Bleyl, U.; Goerdt, S.; Franke, W.W., 2005:
Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes

Yu, Z.; Zhang, Y.; Qiao, M.; Baral, H. , O.; Weber, E.; Zhang, K., 2006 :
Drechslerella brochopaga, the anamorph of Orbilia (Hyalinia) orientalis

Itoh, T.; Onitsuka, T.; Maruyama, T., 2005:
Dredged juveniles of the freshwater unionid mussel Pronodularia japanensis (Unionidae) in Tochigi Prefecture, Japan

Froehner, Sigurd, E., 2001:
Drei neue Alchemilla-Endemiten (Rosaceae) aus den osterreichischen Alpen

Litterski, B.; Adler, A.; Joerns, S., 2006:
Dreifelderwirtschaft - Chance fur den Segetalartenschutz auf ertragsschwachen Standorten

Hubenov, Zdravko, 2005:
Dreissena (Bivalvia: Dreissenidae) - Systematics, autochthonous and anthropogenic areas

Orlova, M.; Golubkov, S.; Kalinina, L.; Ignatieva, N., 2004:
Dreissena polymorpha (Bivalvia: Dreissenidae) in the Neva Estuary (eastern Gulf of Finland, Baltic Sea): is it a biofilter or source for pollution?

Beraudo, M.; Chau, O.; Tinghitella, G.; Chiurco, L.; Astiz, L.; Manuel-Astiz, J., 2006:
Drenaje percutaneo guiado de abscesos abdominales

Fuertes, E.; Olivan, G.; Acon, M., 2004:
Drepanocladus (Amblystegiaceae, Bryopsida) in the Iberian Peninsula

Nadkarni, S.; Jung, P., 2005:
Dressed neurons: modeling neural-glial interactions

Campbell, B.Grambow., 2006:
Dressings, bandages, and splints for wound management in dogs and cats

Kibar, Y.; Avci, A.; Akay, O.; Dayanç, M., 2005:
Dribbling of urine due to ectopic vaginal insertion of an upper pole ureter diagnosed by magnetic resonance urography

Aburuz, S.; Millership, J.; McElnay, J., 2006:
Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin

Toledo, A.Carlos.de.Castro.; Januário, Jé.Nélio.; Rezende, R.Maria.Silva.; Siqueira, A.Lúcia.; Mello, B.Freire.de.; Fialho, E.Ligorio.; Ribeiro, R.Andrade.; Silva, Hélia.Lemos.da.; Pires, E.Carvalho.; Simões, Tá.César.; Greco, D.Bartolomeu., 2005:
Dried blood spots as a practical and inexpensive source for human immunodeficiency virus and hepatitis C virus surveillance

Hooda, S.; Tyagi, P.K., 2003:
Dried goat waste: An egg yolk colourant for laying hens

Ros, A.; Montes-Moran, M.A.; Fuente, E.; Nevskaia, D.M.; Martin, M.J., 2006:
Dried sludges and sludge-based chars for H2S removal at low temperature: influence of sewage sludge characteristics

Westropp, J.L.; Ruby, A.L.; Bailiff, N.L.; Kyles, A.E.; Ling, G.V., 2006:
Dried solidified blood calculi in the urinary tract of cats

Yang, L.; Sturgeon, R., E.; Mester, Z., 2005:
Dried-droplet laser ablation ICP-MS of HPLC fractions for the determination of selenomethionine in yeast

Cereghino, R.; Legalle, M.; Lavandier, P., 2004:
Drift and benthic population structure of the mayfly Rhithrogena semicolorata (Heptageniidae) under natural and hydropeaking conditions

Shapiro, J.L., 2005:
Drift and scaling in estimation of distribution algorithms

Shimada, K.; Urabe, M., 2004:
Drift and upstream movement of Semisulcospira libertina (Caenogastropoda: Pleuroceridae) in a natural stream

Robinson, C.T.; Tockner, K.; Burgherr, P., 2004:
Drift benthos relationships in the seasonal colonization dynamics of alpine streams

Page, B.; Mckenzie, J.; Hindell, M., A.; Goldsworthy, S., D., 2005:
Drift dives by male New Zealand fur seals (Arctocephalus forsteri)

Carlsen, S.C.K.; Spliid, N.H.; Svensmark, B., 2005:
Drift of 10 herbicides after tractor spray application. 1. Secondary drift (evaporation)

Carlsen, S.C.K.; Spliid, N.H.; Svensmark, B., 2005:
Drift of 10 herbicides after tractor spray application. 2. Primary drift (droplet drift)

Peterka, J.; Vasek, M.; Kubecka, J.; Hladik, M.; Hohausova, E., 2004:
Drift of juveniles after riverine spawning of fishes from the Rimov reservoir, Czech Republic

Norton, D., W.; Gaylord, A.-Graves, 2004:
Drift velocities of ice floes in Alaska's northern Chukchi sea flaw zone: Determinants of success by spring subsistence whalers in 2000 and 2001

Dahms, H.U.; Qian, P.Y.an, 2004:
Drift-pump and drift-net-two devices for the collection of bottom-near drifting biota

Ikehara, K.; Hayashida, F., 2003:
Drifted seaweed on a Miho beach in the innermost part of Suruga Bay, central Japan

Lima, E.-Moura; Rissino, J.-Dores; Guimaraes, A.-Costa; Overal, D.-James; Khayat, A.-Salim; De-Souza, P.-Carvalho; Christofolani, D.-Maria; Smith, M.-De-Arruda-Cardoso; Burbano, R.-Rodriguez, 2005:
Drifter technique: A new method to obtain metaphases in Hep-2 cell line cultures

Arroyo, N.-Larissa; Aarnio, K.; Bonsdorff, E., 2006:
Drifting algae as a means of re-colonizing defaunated sediments in the Baltic Sea. A short-term microcosm study

Cadee, Gerhard, C., 2005:
Drifting branches of Crambe maritima L. with fruits

Dempster, T.; Kingsford, M.J., 2004:
Drifting objects as habitat for pelagic juvenile fish off New South Wales, Australia

Downes, B.J.; Bellgrove, A.; Street, J.L., 2005:
Drifting or walking? Colonisation routes used by different instars and species of lotic, macroinvertebrate filter feeders

Barnes, D.; Milner, P., 2005:
Drifting plastic and its consequences for sessile organism dispersal in the Atlantic Ocean

Breuer, E.; Stevenson, A.G.; Howe, J.A.; Carroll, J.; Shimmield, G.B., 2004:
Drill cutting accumulations in the Northern and Central North Sea: a review of environmental interactions and chemical fate

Nweke, C.O.; Okpokwasili, G.C., 2003:
Drilling fluid base oil biodegradation potential of a soil Staphylococcus species

Delance, J.-Henri; Emig, C., C., 2004:
Drilling predation on Gryphus vitreus (Brachiopoda) off the French Mediterranean coasts

Hoffmeister, A.P.; Kowalewski, M.; Baumiller, T.K.; Bambach, R.K., 2004:
Drilling predation on Permian brachiopods and bivalves from the Glass Mountains, west Texas

Brink, E.; Dold, A.P., 2003:
Drimia acarophylla (Hyacinthaceae), a new species from Eastern Cape, South Africa

Dold, A.P.; Brink, E., 2004:
Drimia chalumnensis (Hyacinthaceae - Urgineoideae), a new species from Eastern Cape, South Africa

Edwards, T.J.; Crouch, N.R.; Styles, D., 2005:
Drimia flagellaris (Hyacinthaceae): a new discovery from KwaZulu-Natal

Smit, H.; Gerling, T.; De-Boer, J., 2005:
Dringlichkeit, erfoigsaussicht, chancengleichheit - Grundlagen und verteilungspraxis postmortal gespendeter organe in Deutschland

Tay, R., 2005:
Drink driving enforcement and publicity campaigns: are the policy recommendations sensitive to model specification?

Mündel, T.; King, J.; Collacott, E.; Jones, D.A., 2006:
Drink temperature influences fluid intake and endurance capacity in men during exercise in a hot, dry environment

Hjelland, I.E.; Ofstad, A.P.; Narvestad, J.K.; Berstad, A.; Hausken, T., 2004:
Drink tests in functional dyspepsia: which drink is best?

Greenberg, M.D.; Morral, A.R.; Jain, A.K., 2005:
Drink-driving and DUI recidivists' attitudes and beliefs: a longitudinal analysis

Norbury, C.C., 2006:
Drinking a lot is good for dendritic cells

Varsamos, S.; Bonga, S.W.ndelaar; Charmantier, G.; Flik, G., 2004:
Drinking and Na+/K+ ATPase activity during early development of European sea bass, Dicentrarchus labrax - Ontogeny and short-term regulation following acute salinity changes

Sekii, T.; Shimizu, S.; So, T., 2005:
Drinking and domestic violence: findings from clinical survey of alcoholics

Wechsler, H.; Lee, J.Eun.; Nelson, T.F.; Lee, H., 2003:
Drinking and driving among college students: the influence of alcohol-control policies

Chalder, M.; Elgar, F.J.; Bennett, P., 2005:
Drinking and motivations to drink among adolescent children of parents with alcohol problems

Bell, N.S.; Harford, T.; McCarroll, J.E.; Senier, L., 2004:
Drinking and spouse abuse among U.S. Army soldiers

Bingham, C.Raymond.; Shope, J.T.; Tang, X., 2005:
Drinking behavior from high school to young adulthood: differences by college education

Mukamal, K.J.; Jensen, M.K.; Grønbaek, M.; Stampfer, M.J.; Manson, J.E.; Pischon, T.; Rimm, E.B., 2005:
Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men

Zamboanga, B.L.; Leitkowski, L.K.; Rodríguez, L.; Cascio, K.A., 2005:
Drinking games in female college students: more than just a game?

Chen, L-Hui.; Baker, S.P.; Li, G., 2005:
Drinking history and risk of fatal injury: comparison among specific injury causes

Petzel, David, 2005:
Drinking in Antarctic fishes

Beirness, D.J.; Foss, R.D.; Vogel-Sprott, M., 2004:
Drinking on campus: self-reports and breath tests

Giesbrecht, N.; Ialomiteanu, A.; Anglin, L., 2004:
Drinking patterns and perspectives on alcohol policy: results from two Ontario surveys

Cherpitel, C.J.; Moskalewicz, J.; Swiatkiewicz, G., 2004:
Drinking patterns and problems in emergency services in Poland

Breslow, R.A.; Smothers, B., 2004:
Drinking patterns of older Americans: National Health Interview Surveys, 1997-2001

Wells, S.; Graham, K.; Speechley, M.; Koval, J.J., 2005:
Drinking patterns, drinking contexts and alcohol-related aggression among late adolescent and young adult drinkers

Shimizu, S.; Kim, D.Soo.; Hirota, M., 2004:
Drinking practice and alcohol-related problems: the national representative sample survey for Healthy Japan 21

Oei, T.P.S.; Hasking, P.A.; Young, R.McD., 2005:
Drinking refusal self-efficacy questionnaire-revised (DRSEQ-R): a new factor structure with confirmatory factor analysis

Trim, R.S.; Chassin, L., 2004:
Drinking restraint, alcohol consumption and alcohol dependence among children of alcoholics

Voas, R.B.; Romano, E.; Tippetts, A.Scott.; Furr-Holden, C.Debra.M., 2006:
Drinking status and fatal crashes: which drinkers contribute most to the problem?

Thomas, S.E.; Randall, C.L.; Carrigan, M.H., 2003:
Drinking to cope in socially anxious individuals: a controlled study

Todd, M.; Armeli, S.; Tennen, H.; Carney, M.Anne.; Ball, S.A.; Kranzler, H.R.; Affleck, G., 2005:
Drinking to cope: a comparison of questionnaire and electronic diary reports

Ward, M.H.; Heineman, E.F.; McComb, R.D.; Weisenburger, D.D., 2005:
Drinking water and dietary sources of nitrate and nitrite and risk of glioma

Sobsey, M.D., 2006:
Drinking water and health research: a look to the future in the United States and globally

Simões, L.C.; Azevedo, N.; Pacheco, A.; Keevil, C.W.; Vieira, M.J., 2006:
Drinking water biofilm assessment of total and culturable bacteria under different operating conditions

Yang, C-Yuh., 2004:
Drinking water chlorination and adverse birth outcomes in Taiwan

Infante-Rivard, C., 2004:
Drinking water contaminants, gene polymorphisms, and fetal growth

Rainey, R.C.; Harding, A.K., 2005:
Drinking water quality and solar disinfection: effectiveness in peri-urban households in Nepal

Caetano, R.; McGrath, C.; Ramisetty-Mikler, S.; Field, C.A., 2005:
Drinking, alcohol problems and the five-year recurrence and incidence of male to female and female to male partner violence

Leonard, K.E.; Quigley, B.M.; Collins, R.Lorraine., 2003:
Drinking, personality, and bar environmental characteristics as predictors of involvement in barroom aggression

Fewtrell, L., 2004:
Drinking-water nitrate, methemoglobinemia, and global burden of disease: a discussion

Stringfellow, W.T.; Komada, T.; Chang, L-Yang., 2006:
Drip-feed bioreactor for the treatment of concentrated wastes with minimal dilution

Purcell, K.; Fergie, J., 2004:
Driscoll Children's Hospital respiratory syncytial virus database - Risk factors, treatment and hospital course in 3308 infants and young children, 1997 to 2002

Gany, F.M.; Trinh-Shevrin, C.; Changrani, J., 2004:
Drive-by readings: a creative strategy for tuberculosis control among immigrants

Yannis, G.; Golias, J.; Papadimitriou, E., 2005:
Driver age and vehicle engine size effects on fault and severity in young motorcyclists accidents

Horberry, T.; Anderson, J.; Regan, M.A.; Triggs, T.J.; Brown, J., 2005:
Driver distraction: the effects of concurrent in-vehicle tasks, road environment complexity and age on driving performance

Sagberg, F., 2005:
Driver health and crash involvement: a case-control study

Uc, E.Y.; Rizzo, M.; Anderson, S.W.; Shi, Q.; Dawson, J.D., 2005:
Driver landmark and traffic sign identification in early Alzheimer's disease

Hamilton, W.Ian.; Clarke, T., 2005:
Driver performance modelling and its practical application to railway safety

Uc, E.Y.; Rizzo, M.; Anderson, S.W.; Shi, Q.; Dawson, J.D., 2004:
Driver route-following and safety errors in early Alzheimer disease

Liu, G-Fen.; Han, S.; Liang, D-Hong.; Wang, F-Zhi.; Shi, X-Zhu.; Yu, J.; Wu, Z-Lai., 2003 :
Driver sleepiness and risk of car crashes in Shenyang, a Chinese northeastern city: population-based case-control study

Stutts, J.; Feaganes, J.; Reinfurt, D.; Rodgman, E.; Hamlett, C.; Gish, K.; Staplin, L., 2005:
Driver's exposure to distractions in their natural driving environment

Zhang, W.; Huang, Y.-Hsiang; Roetting, M.; Wang, Y.; Wei, H., 2006:
Driver's views and behaviors about safety in China - What do they NOT know about driving?

Shabsigh, R.; Perelman, M.A.; Laumann, E.O.; Lockhart, D.C., 2004:
Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries

Dummett, Kel, 2006:
Drivers for corporate environmental responsibility (CER)

Kleindorfer, P.R.; Elliott, M.R.; Wang, Y.; Lowe, R.A., 2004:
Drivers of accident preparedness and safety: evidence from the RMP Rule

Rogers, S., D.; Kadar, E., E.; Costall, A., 2005:
Drivers' gaze patterns in braking from three different approaches to a crash barrier

Sordella, R.; Van Aelst, L., 2006:
Driving actin dynamics under the influence of alcohol

Perino, C., I.; Leon-Carrion, J., 2005:
Driving after brain injury

Kostyniuk, L.P.; Shope, J.T., 2003:
Driving and alternatives: older drivers in Michigan

Stewart, A.E.; St Peter, C.C., 2004:
Driving and riding avoidance following motor vehicle crashes in a non-clinical sample: psychometric properties of a new measure

Dahlen, E.R.; Martin, R.C.; Ragan, K.; Kuhlman, M.M., 2005:
Driving anger, sensation seeking, impulsiveness, and boredom proneness in the prediction of unsafe driving

Macdonald, S.; DeSouza, A.; Mann, R.; Chipman, M., 2004:
Driving behavior of alcohol, cannabis, and cocaine abuse treatment clients and population controls

Barsh, R.L.wrence; Marlor, C., 2003:
Driving bison and Blackfoot science

Talbot, A.; Bruce, I.; Cunningham, C.J.; Coen, R.F.; Lawlor, B.A.; Coakley, D.; Walsh, J.B.; O'Neill, D., 2005:
Driving cessation in patients attending a memory clinic

Santos, M.A.S.; Moura, G.; Massey, S.E.; Tuite, M.F., 2004:
Driving change: the evolution of alternative genetic codes

Cohen, H.S.; Wells, J.; Kimball, K.T.; Owsley, C., 2003:
Driving disability and dizziness

Strauss, K.; MacLean, C.; Troy, A.; Littenberg, B., 2006:
Driving distance as a barrier to glycemic control in diabetes

Khandelia, H.; Langham, A.A.; Kaznessis, Y.N., 2006:
Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions

Perlovich, G.L.; Skar, M.; Bauer-Brandl, A., 2003:
Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD

Neirynck, J.; Kowalski, A.S.; Carrara, A.; Ceulemans, R., 2005:
Driving forces for ammonia fluxes over mixed forest subjected to high deposition loads

Olofsson, M.; Sahlin, J.; Ekvall, T.; Sundberg, J., 2005:
Driving forces for import of waste for energy recovery in Sweden

Mulder, C., 2006:
Driving forces from soil invertebrates to ecosystem functioning: the allometric perspective

Burgi, M.; Hersperger, A.M.; Schneeberger, N., 2004:
Driving forces of landscape change - current and new directions

Familoni, B.O.; Abell, T.L.; Gan, Z.; Voeller, G., 2005:
Driving gastric electrical activity with electrical stimulation

Anonymous, 2006:
Driving geckos up the wall

Wingen, M.; Ramaekers, J.G.; Schmitt, J.A.J., 2006:
Driving impairment in depressed patients receiving long-term antidepressant treatment

Schrag, A., 2005:
Driving in Parkinson's disease

Homann, C.N.; Suppan, K.; Homann, B.; Crevenna, R.; Ivanic, G.; Ruzicka, E., 2003:
Driving in Parkinson's disease - a health hazard?

Foley, D.J.; Heimovitz, H.K.; Guralnik, J.M.; Brock, D.B., 2002:
Driving life expectancy of persons aged 70 years and older in the United States

Wouters, K.L.; de Tacconi, N.R.; Konduri, R.; Lezna, R.O.; MacDonnell, F.M., 2006:
Driving multi-electron reactions with photons: dinuclear ruthenium complexes capable of stepwise and concerted multi-electron reduction

Lesch, M.F.; Hancock, P.A., 2004:
Driving performance during concurrent cell-phone use: are drivers aware of their performance decrements?

Daanen, H.A.M.; van de Vliert, E.; Huang, X., 2003:
Driving performance in cold, warm, and thermoneutral environments

Cranney, A.B.; Harrison, A.; Ruhland, L.; Vaidyanath, C.; Graham, I.; Man-Son-Hing, M.; Jaffey, J.; Towheed, T.E.; Anastassiades, T.P.; Dwosh, I.I., 2005:
Driving problems in patients with rheumatoid arthritis

Freeman, E.E.; Gange, S.J.; Muñoz, B.; West, S.K., 2006:
Driving status and risk of entry into long-term care in older adults

Caetano, R.; McGrath, C., 2005:
Driving under the influence (DUI) among U.S. ethnic groups

Jones, A.Wayne., 2005:
Driving under the influence of chlormethiazole

Toennes, S.W.; Kauert, G.F.; Steinmeyer, S.; Moeller, M.R., 2005:
Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms

Leon-Carrion, J.; Dominguez-Morales, M.R.; Martin, J.M.Barroso.Y., 2005:
Driving with cognitive deficits: neurorehabilitation and legal measures are needed for driving again after severe traumatic brain injury

Bardot, B.; Lecoin, L.; Fliniaux, I.; Huillard, E.; Marx, M.; Viallet, J.P., 2004:
Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development

Danek, Janusz, 2005:
Drobnoustroje w nasieniu ogierow

Iwersen-Bergmann, S.; Stein, S.; Schmoldt, A., 2004:
Drogen and Medikamente bei Strassenverkehrsteilnehmern in Hamburg von 1993-2000

Dierich, O.; Soyka, M., 2005:
Drogenanalytik im Speichel mit Immunoassay - Ein Vergleich mit konventionellen Nachweisverfahren im Urin

Schuetz, H.; Pain, A.; Erdmann, F.; Verhoff, M., A.; Weiler, G., 2006:
Drogenscreening im harn - haufige fehlerquellen bei der messung und interpretation

Pascal, P.; Bensiam, F.; Auxenfans, C.; Callu, M.F.; Robert, O.; Damour, O.; Chapuis, F., 2005:
Droit concernant les tissus humains a finalite de recherche

Raby, W.Noël.; Modica, P.A.; Wolintz, R.J.; Murtaugh, K., 2006:
Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension: a case report

Oyetayo, O.O.; Rogers, C.E.; Hofmann, P.O., 2010:
Dronedarone: a new antiarrhythmic agent

Wegener, F.T.; Ehrlich, J.R.; Hohnloser, S.H., 2006:
Dronedarone: an emerging agent with rhythm- and rate-controlling effects

Van der Burg, J.J.W.; Jongerius, P.H.; Van Hulst, K.; Van Limbeek, J.; Rotteveel, J.J., 2006:
Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care

Meningaud, J-Paul.; Pitak-Arnnop, P.; Chikhani, L.; Bertrand, J-Charles., 2005:
Drooling of saliva: a review of the etiology and management options

Lee, H.; Yi, H-Ah.; Lee, S-Ryong.; Ahn, B-Hoon.; Park, B-Rim., 2005:
Drop attacks in elderly patients secondary to otologic causes with Meniere's syndrome or non-Meniere peripheral vestibulopathy

Boddaert, J.; Verny, M., 2005:
Drop attacks in older adults: systematic assessment has a high diagnostic yield

Brantberg, K.; Ishiyama, A.; Baloh, R.W., 2005:
Drop attacks secondary to superior canal dehiscence syndrome

Luo, G.S.; Li, H.B.; Tang, X.J.; Wang, J.D., 2004:
Drop breakage in a coalescence-dispersion pulsed-sieve-plate extraction column

Barhate, R.S.; Patil, G.; Srinivas, N.D.; Raghavarao, K.S.M.S., 2004:
Drop formation in aqueous two-phase systems

Del Monte, U.; Statuto, M., 2004:
Drop of connexins: a possible link between aging and cancer?

Sugiyama, M.; Koimaru, H.; Shiba, M.; Ono, E.; Nagata, T.; Ito, T., 2006:
Drop of egg production in chickens by experimental infection with an avian metapneumovirus strain PLE8T1 derived from swollen head syndrome and the application to evaluate vaccine

Alexander, A.; Subramanian, N.; Buxbaum, J.N.; Jacobson, D.R., 2004:
Drop-in, drop-out allele-specific PCR: a highly sensitive, single-tube method

Eberhart, L.H.J.; Morin, A.M.; Hoerle, S.; Wulf, H.; Geldner, Götz., 2004:
Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy

Shiga, T.; Yong, S.; Carino, J.; Murray, P., A.; Damron, D., S., 2005:
Droperidol inhibits fits intracellular Ca2+ myofilament Ca2+ sensitivity, and contraction in rat ventricular myocytes

Chabert, M.; Dorfman, K.D.; Viovy, J-Louis., 2005:
Droplet fusion by alternating current (AC) field electrocoalescence in microchannels

Stainier, C.D.stain, M.; Schiffers, B.L.beau, F., 2006:
Droplet size spectra and drift effect of two phenmedipham formulations and four adjuvants mixtures

Schwartz, J.A.; Vykoukal, J.V.; Gascoyne, P.R.C., 2004:
Droplet-based chemistry on a programmable micro-chip

Srinivasan, V.; Pamula, V.K.; Fair, R.B., 2004:
Droplet-based microfluidic lab-on-a-chip for glucose detection

Kemmler, G.; Hummer, M.; Widschwendter, C.; Fleischhacker, W.Wolfgang., 2005:
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis

Pelagotti, F.; Santarlasci, B.; Vacca, F.; Trippoli, S.; Messori, A., 2003:
Dropout rates with olanzapine or risperidone: a multi-centre observational study

Roberts, D.J.; Chun, H.M., 2005:
Dropped gallstone as a nidus of intra-abdominal abscess complicated by empyema

Yanmiş, I.; Tunay, S.; Oğuz, E.; Yildiz, C.; Ozkan, Hüseyin.; Kirdemir, V., 2004:
Dropping of an EndoButton into the knee joint 2 years after anterior cruciate ligament repair using proximal fixation methods

DeSoto, M.Catherine., 2003:
Drops in estrogen levels affect brain, body and behavior: reported relationship between attitudes and menopausal symptoms

Tarlao, A.; Tunis, G.; Venturini, S., 2005:
Dropstones, pseudoplanktonic forms and deep-water decapod crustaceans within a Lutetian condensed succession of central Istria (Croatia): relation to palaeoenvironmental evolution and palaeogeography

Bi, X.; Srikanta, D.; Fanti, L.; Pimpinelli, S.; Badugu, R.; Kellum, R.; Rong, Y.S., 2005:
Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance

Bi, X.; Gong, M.; Srikanta, D.; Rong, Y.S., 2005:
Drosophila ATM and Mre11 are essential for the G2/M checkpoint induced by low-dose irradiation

Qi, D.; Larsson, J.; Mannervik, M., 2004:
Drosophila Ada2b is required for viability and normal histone H3 acetylation

Möller, Aé.; Avila, F.W.; Erickson, J.W.; Jäckle, H., 2005:
Drosophila BAP60 is an essential component of the Brahma complex, required for gene activation and repression

Read, R.D.; Bach, E.A.; Cagan, R.L., 2004:
Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways

Zordan, M.A.; Massironi, M.; Ducato, M.Giovanna.; T.K.onnie, G.; Costa, R.; Reggiani, C.; Chagneau, C.; Martin, J-René.; Megighian, A., 2005:
Drosophila CAKI/CMG protein, a homolog of human CASK, is essential for regulation of neurotransmitter vesicle release

Savvidou, E.; Cobbe, N.; Steffensen, Søren.; Cotterill, S.; Heck, M.M.S., 2005:
Drosophila CAP-D2 is required for condensin complex stability and resolution of sister chromatids

Karandikar, U.C.; Shaffer, J.; Bishop, C.P.; Bidwai, A.P., 2005:
Drosophila CK2 phosphorylates Deadpan, a member of the HES family of basic-helix-loop-helix (bHLH) repressors

Karandikar, U.C.; Trott, R.L.; Yin, J.; Bishop, C.P.; Bidwai, A.P., 2004:
Drosophila CK2 regulates eye morphogenesis via phosphorylation of E(spl)M8

Bose, A.; Kahali, B.; Zhang, S.; Lin, J-Ming.; Allada, R.; Karandikar, U.; Bidwai, A.P., 2006:
Drosophila CK2 regulates lateral-inhibition during eye and bristle development

Collins, B.; Mazzoni, E.O.; Stanewsky, R.; Blau, J., 2006:
Drosophila CRYPTOCHROME is a circadian transcriptional repressor

Matera, A.Gregory., 2006:
Drosophila Cajal bodies: accessories not included

Swan, A.; Barcelo, G.; Schüpbach, T., 2005:
Drosophila Cks30A interacts with Cdk1 to target Cyclin A for destruction in the female germline

Collier, L.S.; Suyama, K.; Anderson, J.H.; Scott, M.P., 2004:
Drosophila Costal1 mutations are alleles of protein kinase A that modulate hedgehog signaling

Huertas, D.; Cortés, A.; Casanova, J.; Azorín, F., 2004:
Drosophila DDP1, a multi-KH-domain protein, contributes to centromeric silencing and chromosome segregation

Meulener, M.; Whitworth, A.J.; Armstrong-Gold, C.E.; Rizzu, P.; Heutink, P.; Wes, P.D.; Pallanck, L.J.; Bonini, N.M., 2005:
Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease

Park, J.; Kim, S.Yun.; Cha, G-Ho.; Lee, S.Bae.; Kim, S.; Chung, J., 2005:
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction

Takeuchi, R.; Ruike, T.; Nakamura, R-ichi.; Shimanouchi, K.; Kanai, Y.; Abe, Y.; Ihara, A.; Sakaguchi, K., 2006:
Drosophila DNA polymerase zeta interacts with recombination repair protein 1, the Drosophila homologue of human abasic endonuclease 1

Bergman, C.M.; Carlson, J.W.; Celniker, S.E., 2004:
Drosophila DNase I footprint database: a systematic genome annotation of transcription factor binding sites in the fruitfly, Drosophila melanogaster

Yu, D.; Keene, A.C.; Srivatsan, A.; Waddell, S.; Davis, R.L., 2005:
Drosophila DPM neurons form a delayed and branch-specific memory trace after olfactory classical conditioning

Biswas, R.; Stein, D.; Stanley, E.Richard., 2005:
Drosophila Dok is required for embryonic dorsal closure

Belenkaya, T.Y.; Han, C.; Yan, D.; Opoka, R.J.; Khodoun, M.; Liu, H.; Lin, X., 2004:
Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans

Moon, N-Sung.; Frolov, M.V.; Kwon, E-Jeong.; Di Stefano, L.; Dimova, D.K.; Morris, E.J.; Taylor-Harding, B.; White, K.; Dyson, N.J., 2005:
Drosophila E2F1 has context-specific pro- and antiapoptotic properties during development

Radford, S.J.; Goley, E.; Baxter, K.; McMahan, S.; Sekelsky, J., 2005:
Drosophila ERCC1 is required for a subset of MEI-9-dependent meiotic crossovers

Wang, D.; Xu, M.; Liu, J.; Wan, Y.; Deng, H.; Dou, F.; Xie, W., 2006:
Drosophila Ecp is a novel ribosome associated protein interacting with dRPL5

Boyle, M.; Nighorn, A.; Thomas, J.B., 2006:
Drosophila Eph receptor guides specific axon branches of mushroom body neurons

Dimitrijevic, N.; Dzitoyeva, S.; Satta, R.; Imbesi, M.; Yildiz, S.; Manev, H., 2005:
Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB)

Hyun, S.; Lee, Y.; Hong, S-Tae.; Bang, S.; Paik, D.; Kang, J.; Shin, J.; Lee, J.; Jeon, K.; Hwang, S.; Bae, E.; Kim, J., 2005:
Drosophila GPCR Han is a receptor for the circadian clock neuropeptide PDF

Cenci, C.; Gould, A.P., 2005:
Drosophila Grainyhead specifies late programmes of neural proliferation by regulating the mitotic activity and Hox-dependent apoptosis of neuroblasts

Kuranaga, E.; Kanuka, H.; Tonoki, A.; Takemoto, K.; Tomioka, T.; Kobayashi, M.; Hayashi, S.; Miura, M., 2006:
Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs

Shapiro, R.S.; Anderson, K.V., 2006:
Drosophila Ik2, a member of the I kappa B kinase family, is required for mRNA localization during oogenesis

Chang, C-Jui.; Goulding, S.; Adams, R.R.; Earnshaw, W.C.; Carmena, M., 2006:
Drosophila Incenp is required for cytokinesis and asymmetric cell division during development of the nervous system

Sarpal, R.; Todi, S.V.; Sivan-Loukianova, E.; Shirolikar, S.; Subramanian, N.; Raff, E.C.; Erickson, J.W.; Ray, K.; Eberl, D.F., 2003:
Drosophila KAP interacts with the kinesin II motor subunit KLP64D to assemble chordotonal sensory cilia, but not sperm tails

Savoian, M.S.; Gatt, M.K.; Riparbelli, M.G.; Callaini, G.; Glover, D.M., 2004:
Drosophila Klp67A is required for proper chromosome congression and segregation during meiosis I

Moussian, B.; Tång, E.; Tonning, A.; Helms, S.; Schwarz, H.; Nüsslein-Volhard, C.; Uv, A.E., 2005:
Drosophila Knickkopf and Retroactive are needed for epithelial tube growth and cuticle differentiation through their specific requirement for chitin filament organization

Arquier, N.; Bourouis, M.; Colombani, J.; Léopold, P., 2005:
Drosophila Lk6 kinase controls phosphorylation of eukaryotic translation initiation factor 4E and promotes normal growth and development

He, Y.; Emoto, K.; Fang, X.; Ren, N.; Tian, X.; Jan, Y-Nung.; Adler, P.N., 2005:
Drosophila Mob family proteins interact with the related tricornered (Trc) and warts (Wts) kinases

Jin, Z.; Homola, E.M.; Goldbach, P.; Choi, Y.; Brill, J.A.; Campbell, S.D., 2005:
Drosophila Myt1 is a Cdk1 inhibitory kinase that regulates multiple aspects of cell cycle behavior during gametogenesis

Ting, C-Yuan.; Yonekura, S.; Chung, P.; Hsu, S-Ning.; Robertson, H.M.; Chiba, A.; Lee, C-Hon., 2005:
Drosophila N-cadherin functions in the first stage of the two-stage layer-selection process of R7 photoreceptor afferents

Sakata, T.; Sakaguchi, H.; Tsuda, L.; Higashitani, A.; Aigaki, T.; Matsuno, K.; Hayashi, S., 2004:
Drosophila Nedd4 regulates endocytosis of notch and suppresses its ligand-independent activation

Prigent, C.; Glover, D.M.; Giet, Régis., 2004:
Drosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failure

Gu, G.; Yang, J.; Mitchell, K.A.; O'Tousa, J.E., 2004 :
Drosophila ninaB and ninaD act outside of retina to produce rhodopsin chromophore

Xu, P.; Atkinson, R.; Jones, D.N.M.; Smith, D.P., 2005:
Drosophila OBP LUSH is required for activity of pheromone-sensitive neurons

Kim, S-Eun.; Cho, J-Young.; Kim, K-Sup.; Lee, S-Jae.; Lee, K-Hoo.; Choi, K-Yell., 2004:
Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells

Adelman, K.; Wei, W.; Ardehali, M.Behfar.; Werner, J.; Zhu, B.; Reinberg, D.; Lis, J.T., 2005:
Drosophila Paf1 modulates chromatin structure at actively transcribed genes

Teixeira, Lís.; Rabouille, C.; Rørth, P.; Ephrussi, A.; Vanzo, N.F., 2003:
Drosophila Perilipin/ADRP homologue Lsd2 regulates lipid metabolism

Zhu, X.; Sen, J.; Stevens, L.; Goltz, J.S.; Stein, D., 2005:
Drosophila pipe protein activity in the ovary and the embryonic salivary gland does not require heparan sulfate glycosaminoglycans

Gao, Z.; Joseph, E.; Ruden, D.Mark.; Lu, X., 2004:
Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility

Ayoob, J.C.; Terman, J.R.; Kolodkin, A.L., 2006:
Drosophila Plexin B is a Sema-2a receptor required for axon guidance

Abrescia, C.; Sjöstrand, D.; Kjaer, S.; Ibáñez, C.F., 2005:
Drosophila RET contains an active tyrosine kinase and elicits neurotrophic activities in mammalian cells

Dubrovsky, E.B.; Dubrovskaya, V.A.; Levinger, L.; Schiffer, S.; Marchfelder, A., 2004:
Drosophila RNase Z processes mitochondrial and nuclear pre-tRNA 3' ends in vivo

Verdier, V.; Johndrow, J.E.; Betson, M.; Chen, G-Chao.; Hughes, D.A.; Parkhurst, S.M.; Settleman, J., 2006:
Drosophila Rho-kinase (DRok) is required for tissue morphogenesis in diverse compartments of the egg chamber during oogenesis

Sanny, J.; Chui, V.; Langmann, C.; Pereira, C.; Zahedi, B.; Harden, N., 2006:
Drosophila RhoGAP68F is a putative GTPase activating protein for RhoA participating in gastrulation

Rogers, S.L.; Wiedemann, U.; Häcker, U.; Turck, C.; Vale, R.D., 2004:
Drosophila RhoGEF2 associates with microtubule plus ends in an EB1-dependent manner

David, N., B.; Martin, C., A.; Segalen, M.; Rosenfeld, F.; Schweisguth, F.; Bellaiche, Y., 2005:
Drosophila Ric-8 regulates G alpha i cortical localization to promote G alpha i-dependent planar orientation of the mitotic spindle during asymmetric cell division

Tenney, K.; Gerber, M.; Ilvarsonn, A.; Schneider, J.; Gause, M.; Dorsett, D.; Eissenberg, J.C.; Shilatifard, A., 2006:
Drosophila Rtf1 functions in histone methylation, gene expression, and Notch signaling

Kalinina, E.; Fontenele-Neto, J.D.; Fricker, L.D., 2006:
Drosophila S2 cells produce multiple forms of carboxypeptidase D with different intracellular distributions

Cheng, L.W.; Portnoy, D.A., 2003:
Drosophila S2 cells: an alternative infection model for Listeria monocytogenes

Buescher, M.; Svendsen, P.C.; Tio, M.; Miskolczi-McCallum, C.; Tear, G.; Brook, W.J.; Chia, W., 2004:
Drosophila T box proteins break the symmetry of hedgehog-dependent activation of wingless

Zhuang, Z-Heng.; Sun, L.; Kong, L.; Hu, J-Hao.; Yu, M-Can.; Reinach, P.; Zang, J-Wu.; Ge, B-Xue., 2005:
Drosophila TAB2 is required for the immune activation of JNK and NF-kappaB

Hyman, C.A.; Bartholin, L.; Newfeld, S.J.; Wotton, D., 2003:
Drosophila TGIF proteins are transcriptional activators

Montell, C., 2005:
Drosophila TRP channels

Wakiyama, M.; Matsumoto, T.; Yokoyama, S., 2005:
Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cells

Abaza, I.; Coll, O.; Patalano, S.; Gebauer, Fátima., 2006:
Drosophila UNR is required for translational repression of male-specific lethal 2 mRNA during regulation of X-chromosome dosage compensation

Smith, M.; Bhaskar, V.; Fernandez, J.; Courey, A.J., 2004:
Drosophila Ulp1, a nuclear pore-associated SUMO protease, prevents accumulation of cytoplasmic SUMO conjugates

Pulipparacharuvil, S.; Akbar, M.Ali.; Ray, S.; Sevrioukov, E.A.; Haberman, A.S.; Rohrer, J.; Krämer, H., 2005:
Drosophila Vps16A is required for trafficking to lysosomes and biogenesis of pigment granules

Stumpff, J.; Duncan, T.; Homola, E.; Campbell, S.D.; Su, T.Tin., 2004:
Drosophila Wee1 kinase regulates Cdk1 and mitotic entry during embryogenesis

Zhai, L.; Chaturvedi, D.; Cumberledge, S., 2004:
Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine

Ganguly, A.; Jiang, J.; Ip, Y.Tony., 2005:
Drosophila WntD is a target and an inhibitor of the Dorsal/Twist/Snail network in the gastrulating embryo

Sano, Y.; Akimaru, H.; Okamura, T.; Nagao, T.; Okada, M.; Ishii, S., 2005:
Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase

Benach, J.; Winberg, J-Olof.; Svendsen, J-Sigurd.; Atrian, Sílvia.; Gonzàlez-Duarte, R.; Ladenstein, R., 2004:
Drosophila alcohol dehydrogenase: acetate-enzyme interactions and novel insights into the effects of electrostatics on catalysis

Mathew, D.; Popescu, A.; Budnik, V., 2003:
Drosophila amphiphysin functions during synaptic Fasciclin II membrane cycling

Vilela, C., R.; Valente, V., L.S.; Basso-Da-Silva, L., 2004:
Drosophila angustibucca Duda sensu Frota-Pessoa is an undescribed species (Diptera, Drosophilidae)

Doerflinger, Hélène.; Benton, R.; Torres, I.L.; Zwart, M.F.; St Johnston, D., 2006:
Drosophila anterior-posterior polarity requires actin-dependent PAR-1 recruitment to the oocyte posterior

Deshpande, G.; Calhoun, G.; Schedl, P., 2005:
Drosophila argonaute-2 is required early in embryogenesis for the assembly of centric/centromeric heterochromatin, nuclear division, nuclear migration, and germ-cell formation

Wolf, M.J.; Amrein, H.; Izatt, J.A.; Choma, M.A.; Reedy, M.C.; Rockman, H.A., 2006:
Drosophila as a model for the identification of genes causing adult human heart disease

Koh, Young-Ho, 2006:
Drosophila as a model organism for investigating molecular and cellular etiologies underlying complex neurological disorders in humans

Oikemus, S.R.; McGinnis, N.; Queiroz-Machado, J.; Tukachinsky, H.; Takada, S.; Sunkel, C.E.; Brodsky, M.H., 2004:
Drosophila atm/telomere fusion is required for telomeric localization of HP1 and telomere position effect

Mackay, T.F.; Lyman, R.F., 2005:
Drosophila bristles and the nature of quantitative genetic variation

Perrin, L.; Monier, B.; Ponzielli, R.; Astier, M.; Semeriva, M., 2004:
Drosophila cardiac tube organogenesis requires multiple phases of Hox activity

Daish, T.J.; Mills, K.; Kumar, S., 2004:
Drosophila caspase DRONC is required for specific developmental cell death pathways and stress-induced apoptosis

Kanuka, H.; Kuranaga, E.; Takemoto, K.; Hiratou, T.; Okano, H.; Miura, M., 2005:
Drosophila caspase transduces Shaggy/GSK-3 beta kinase activity in neural precursor development

Nicolas, E.; Preat, T., 2005:
Drosophila central brain formation requires Robo proteins

Naim, V.; Imarisio, S.; Di Cunto, F.; Gatti, M.; Bonaccorsi, S., 2004:
Drosophila citron kinase is required for the final steps of cytokinesis

Valdeolmillos, A.; Rufas, J.S.; Suja, Jé.A.; Vass, S.; Heck, M.M.S.; Martínez-A, C.; Barbero, Jé.L., 2004:
Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis

Faivre-Sarrailh, C.; Banerjee, S.; Li, J.; Hortsch, M.; Laval, M.; Bhat, M.A., 2004:
Drosophila contactin, a homolog of vertebrate contactin, is required for septate junction organization and paracellular barrier function

Glasscock, E.; Tanouye, M.A., 2005:
Drosophila couch potato mutants exhibit complex neurological abnormalities including epilepsy phenotypes

Kiehart, D.P.; Franke, J.D.; Chee, M.K.; Montague, R.A.; Chen, T-Ling.; Roote, J.; Ashburner, M., 2004:
Drosophila crinkled, mutations of which disrupt morphogenesis and cause lethality, encodes fly myosin VIIA

Nakamura, A.; Sato, K.; Hanyu-Nakamura, K., 2004:
Drosophila cup is an eIF4E binding protein that associates with Bruno and regulates oskar mRNA translation in oogenesis

Frei, C.; Edgar, B.A., 2004:
Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth

Costa, E.; Canudas, S.; Garcia-Bassets, I.; Pérez, S.; Fernández, I.; Giralt, E.; Azorín, F.; Espinás, M.Lluïsa., 2006:
Drosophila dSAP18 is a nuclear protein that associates with chromosomes and the nuclear matrix, and interacts with pinin, a protein factor involved in RNA splicing

Takata, K-ichi.; Yoshida, H.; Yamaguchi, M.; Sakaguchi, K., 2004:
Drosophila damaged DNA-binding protein 1 is an essential factor for development

Lin, M-Der.; Fan, S-Jung.; Hsu, W-Shan.; Chou, T-Bin., 2006:
Drosophila decapping protein 1, dDcp1, is a component of the oskar mRNP complex and directs its posterior localization in the oocyte

Hori, K.; Fostier, M.; Ito, M.; Fuwa, T.J.; Go, M.J.; Okano, H.; Baron, M.; Matsuno, K., 2004:
Drosophila deltex mediates suppressor of Hairless-independent and late-endosomal activation of Notch signaling

Min, K-Jin.; Tatar, M., 2005:
Drosophila diet restriction in practice: do flies consume fewer nutrients?

Affleck, J.G.; Al-Batayneh, K.M.; Neumann, K.; Cole, S.P.C.; Walker, V.K., 2005:
Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells

Hayashi, Y.; Kato, M.; Seto, H.; Yamaguchi, M., 2006:
Drosophila distal-less negatively regulates dDREF by inhibiting its DNA binding activity

Keene, A.C.; Krashes, M.J.; Leung, B.; Bernard, J.A.; Waddell, S., 2006:
Drosophila dorsal paired medial neurons provide a general mechanism for memory consolidation

Thomer, M.; May, N.R.; Aggarwal, B.D.; Kwok, G.; Calvi, B.R., 2004:
Drosophila double-parked is sufficient to induce re-replication during development and is regulated by cyclin E/CDK2

Preuss, F.; Fan, J-Yuan.; Kalive, M.; Bao, S.; Schuenemann, E.; Bjes, E.S.; Price, J.L., 2004:
Drosophila doubletime mutations which either shorten or lengthen the period of circadian rhythms decrease the protein kinase activity of casein kinase I

Hortsch, M., 2003:
Drosophila Echinoid is an antagonist of Egfr signalling, but is not a member of the L1-type family of cell adhesion molecules

Anonymous, 2006:
Drosophila elegans Bock & Wheeler, 1972 (Insecta, Diptera): specific name conserved

Wang, W.; Struhl, G., 2004:
Drosophila Epsin mediates a select endocytic pathway that DSL ligands must enter to activate Notch

Langevin, J.; Morgan, M.J.; Sibarita, J-Baptiste.; Aresta, S.; Murthy, M.; Schwarz, T.; Camonis, J.; Bellaïche, Y., 2005:
Drosophila exocyst components Sec5, Sec6, and Sec15 regulate DE-Cadherin trafficking from recycling endosomes to the plasma membrane

Lim, J.; Choi, K-Wook., 2004:
Drosophila eye disc margin is a center for organizing long-range planar polarity

Mathews, W.R.; Wang, F.; Eide, D.J.; Van Doren, M., 2004:
Drosophila fear of intimacy encodes a Zrt/IRT-like protein (ZIP) family zinc transporter functionally related to mammalian ZIP proteins

Swan, A.; Schüpbach, T., 2005:
Drosophila female meiosis and embryonic syncytial mitosis use specialized Cks and CDC20 proteins for cyclin destruction

Peng, Y.; Stoleru, D.; Levine, J.D.; Hall, J.C.; Rosbash, M., 2003:
Drosophila free-running rhythms require intercellular communication

Cairrão, Fátima.; Arraiano, Cília.; Newbury, S., 2005:
Drosophila gene tazman, an orthologue of the yeast exosome component Rrp44p/Dis3, is differentially expressed during development

Resino, J.; García-Bellido, A., 2004:
Drosophila genetic variants that change cell size and rate of proliferation affect cell communication and hence patterning

Lee, L.A.; Lee, E.; Anderson, M.A.; Vardy, L.; Tahinci, E.; Ali, S.M.; Kashevsky, H.; Benasutti, M.; Kirschner, M.W.; Orr-Weaver, T.L., 2005:
Drosophila genome-scale screen for PAN GU kinase substrates identifies Mat89Bb as a cell cycle regulator

Kohyama-Koganeya, A.; Sasamura, T.; Oshima, E.; Suzuki, E.; Nishihara, S.; Ueda, R.; Hirabayashi, Y., 2004:
Drosophila glucosylceramide synthase: a negative regulator of cell death mediated by proapoptotic factors

Dutta, D.; Shaw, S.; Maqbool, T.; Pandya, H.; Vijayraghavan, K., 2005:
Drosophila Heartless acts with Heartbroken/Dof in muscle founder differentiation

Marek, L.R.; Bale, A.E., 2006:
Drosophila homologs of FANCD2 and FANCL function in DNA repair

Majumdar, A.; Ramagiri, S.; Rikhy, R., 2006:
Drosophila homologue of Eps15 is essential for synaptic vesicle recycling

Vodovar, N.; Vinals, M.; Liehl, P.; Basset, A.; Degrouard, J.; Spellman, P.; Boccard, Fédéric.; Lemaitre, B., 2005:
Drosophila host defense after oral infection by an entomopathogenic Pseudomonas species

Kambris, Z.; Brun, S.; Jang, I-Hwan.; Nam, H-Jin.; Romeo, Y.; Takahashi, K.; Lee, W-Jae.; Ueda, R.; Lemaitre, B., 2006:
Drosophila immunity: a large-scale in vivo RNAi screen identifies five serine proteases required for Toll activation

Marsh, J.Lawrence.; Thompson, L.Michels., 2006:
Drosophila in the study of neurodegenerative disease

Fischer, J.A.; Acosta, S.; Kenny, A.; Cater, C.; Robinson, C.; Hook, J., 2004:
Drosophila klarsicht has distinct subcellular localization domains for nuclear envelope and microtubule localization in the eye

Teleman, A.A.; Maitra, S.; Cohen, S.M., 2006:
Drosophila lacking microRNA miR-278 are defective in energy homeostasis

Brummel, T.; Ching, A.; Seroude, L.; Simon, A.F.; Benzer, S., 2004:
Drosophila lifespan enhancement by exogenous bacteria

Fauny, J.Daniel.; Silber, Jël.; Zider, A., 2005:
Drosophila Lipid Storage Droplet 2 gene (Lsd-2) is expressed and controls lipid storage in wing imaginal discs

Phillips, Kathryn, 2004:
Drosophila lose their boost

Rattner, B.P.; Meller, V.H., 2004 :
Drosophila male-specific lethal 2 protein controls sex-specific expression of the roX genes

D'Alterio, C.; Tran, D.D.D.; Yeung, M.W.Y.Au.; Hwang, M.S.H.; Li, M.A.; Arana, C.J.; Mulligan, V.K.; Kubesh, M.; Sharma, P.; Chase, M.; Tepass, U.; Godt, D., 2005:
Drosophila melanogaster Cad99C, the orthologue of human Usher cadherin PCDH15, regulates the length of microvilli

Gisselmann, G.; Plonka, J.; Pusch, H.; Hatt, H., 2004:
Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric GABA-gated and cation channels

Brodsky, M.H.; Weinert, B.T.; Tsang, G.; Rong, Y.S.; McGinnis, N.M.; Golic, K.G.; Rio, D.C.; Rubin, G.M., 2004:
Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage

Thomas, J.E.; Rylett, C.M.; Carhan, A.; Bland, N.D.; Bingham, R.J.; Shirras, A.D.; Turner, A.J.; Isaac, R.Elwyn., 2004:
Drosophila melanogaster NEP2 is a new soluble member of the neprilysin family of endopeptidases with implications for reproduction and renal function

Castro, J.P.; Carareto, C.M.A., 2004:
Drosophila melanogaster P transposable elements: mechanisms of transposition and regulation

Vaché, C.; Camares, O.; D.G.aeve, F.; Dastugue, B.; Meiniel, A.; Vaury, C.; Pellier, S.; Leoz-Garziandia, E.; Bamdad, M., 2006:
Drosophila melanogaster p-glycoprotein: a membrane detoxification system toward polycyclic aromatic hydrocarbon pollutants

Malmanche, N.; Clark, D.V., 2004:
Drosophila melanogaster Prat, a purine de novo synthesis gene, has a pleiotropic maternal-effect phenotype

Williams, M.J.; Ando, I.; Hultmark, D., 2005:
Drosophila melanogaster Rac2 is necessary for a proper cellular immune response

Elwell, C.; Engel, J.N., 2005:
Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells

Acharya, U.; Edwards, M.Beth.; Jorquera, R.A.; Silva, H.; Nagashima, K.; Labarca, P.; Acharya, J.K., 2006:
Drosophila melanogaster Scramblases modulate synaptic transmission

Spresser, C.R.; Carlson, K.A., 2005:
Drosophila melanogaster as a complementary system for studying HIV-1-related genes and proteins

Needham, A.J.; Kibart, M.; Crossley, H.; Ingham, P.W.; Foster, S.J., 2004:
Drosophila melanogaster as a model host for Staphylococcus aureus infection

Hagedorn, E.J.; Bayraktar, J.L.; Kandachar, V.R.; Bai, T.; Englert, D.M.; Chang, H.C., 2006:
Drosophila melanogaster auxilin regulates the internalization of Delta to control activity of the Notch signaling pathway

Vérollet, C.; Colombié, N.; Daubon, T.; Bourbon, H-Marc.; Wright, M.; Raynaud-Messina, B., 2006:
Drosophila melanogaster gamma-TuRC is dispensable for targeting gamma-tubulin to the centrosome and microtubule nucleation

Guedes, S.de.Morais.; Vitorino, R.; Tomer, K.; Domingues, M.Rosário.M.; Correia, A.J.Ferrer.; Amado, F.; Domingues, P., 2003:
Drosophila melanogaster larval hemolymph protein mapping

Dillon, M.E.; Frazier, M.R., 2006:
Drosophila melanogaster locomotion in cold thin air

Ashburner, M.; Bergman, C.M., 2005:
Drosophila melanogaster: a case study of a model genomic sequence and its consequences

Song, Y-Han., 2005:
Drosophila melanogaster: a model for the study of DNA damage checkpoint response

Roberts, D.B., 2006:
Drosophila melanogaster: the model organism

Teleman, A.A.; Chen, Y-Wen.; Cohen, S.M., 2005:
Drosophila Melted modulates FOXO and TOR activity

Aboobaker, A.Aziz.; Tomancak, P.; Patel, N.; Rubin, G.M.; Lai, E.C., 2005:
Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development

Matsushima, Y.; Garesse, R.; Kaguni, L.S., 2004:
Drosophila mitochondrial transcription factor B2 regulates mitochondrial DNA copy number and transcription in schneider cells

Manev, H.; Dimitrijevic, N., 2004:
Drosophila model for in vivo pharmacological analgesia research

Whitworth, A.J.; Wes, P.D.; Pallanck, L.J., 2006:
Drosophila models pioneer a new approach to drug discovery for Parkinson's disease

Mendive, F.M.; Van Loy, T.; Claeysen, S.; Poels, J.; Williamson, M.; Hauser, F.; Grimmelikhuijzen, C.J.P.; Vassart, G.; Vanden Broeck, J., 2005:
Drosophila molting neurohormone bursicon is a heterodimer and the natural agonist of the orphan receptor DLGR2

Cammarato, A.; Hatch, V.; Saide, J.; Craig, R.; Sparrow, J.C.; Tobacman, L.S.; Lehman, W., 2004:
Drosophila muscle regulation characterized by electron microscopy and three-dimensional reconstruction of thin filament mutants

Watanabe, S.; Ikebe, R.; Ikebe, M., 2006 :
Drosophila myosin VIIA is a high duty ratio motor with a unique kinetic mechanism

Wang, H.; Chia, W., 2004:
Drosophila neural progenitor polarity and asymmetric division

Karcavich, R.; Doe, C.Q., 2004:
Drosophila neuroblast 7-3 cell lineage: a model system for studying programmed cell death, Notch/Numb signaling, and sequential specification of ganglion mother cell identity

Yu, F.; Kuo, C.T.; Jan, Y.Nung., 2006:
Drosophila neuroblast asymmetric cell division: recent advances and implications for stem cell biology

Wen, T.; Parrish, C.A.; Xu, D.; Wu, Q.; Shen, P., 2005:
Drosophila neuropeptide F and its receptor, NPFR1, define a signaling pathway that acutely modulates alcohol sensitivity

Cui, W.; Sproul, L.R.; Gustafson, S.M.; Matthies, H.J.G.; Gilbert, S.P.; Hawley, R.S., 2005:
Drosophila Nod protein binds preferentially to the plus ends of microtubules and promotes microtubule polymerization in vitro

Wahlström, G.; Lahti, V-Pekka.; Pispa, J.; Roos, C.; Heino, T.I., 2004:
Drosophila non-muscle alpha-actinin is localized in nurse cell actin bundles and ring canals, but is not required for fertility

Barros, C.S.; Phelps, C.B.; Brand, A.H., 2003:
Drosophila nonmuscle myosin II promotes the asymmetric segregation of cell fate determinants by cortical exclusion rather than active transport

de Rosny, E.; de Groot, A.; Jullian-Binard, C.; Gaillard, J.; Borel, F.; Pebay-Peyroula, E.; Fontecilla-Camps, J.Carlos.; Jouve, Hélène.M., 2006:
Drosophila nuclear receptor E75 is a thiolate hemoprotein

Bartoszewski, Sławomir.; Luschnig, S.; Desjeux, I.; Grosshans, Jörg.; Nüsslein-Volhard, C., 2004 :
Drosophila p24 homologues eclair and baiser are necessary for the activity of the maternally expressed Tkv receptor during early embryogenesis

Kim, T.-Hee; Park, S.-Young; Chung, H.-Young; Kim, B.-Gee; Yoo, M.-Ae; Kim, Y.-Shin, 2005:
Drosophila p53 upregulates VDAC gene expression that is linked to apoptosis

Pesah, Y.; Pham, T.; Burgess, H.; Middlebrooks, B.; Verstreken, P.; Zhou, Y.; Harding, M.; Bellen, H.; Mardon, G., 2004:
Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress

Choe, K-Min.; Lee, H.; Anderson, K.V., 2005:
Drosophila peptidoglycan recognition protein LC (PGRP-LC) acts as a signal-transducing innate immune receptor

Tulin, A.; Naumova, N.M.; Menon, A.K.; Spradling, A.C., 2005:
Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing

Maier, D.; Hausser, A.; Nagel, A.C.; Link, G.; Kugler, S.J.; Wech, I.; Pfizenmaier, K.; Preiss, A., 2006:
Drosophila protein kinase D is broadly expressed and a fraction localizes to the Golgi compartment

Qi, D.; Jin, H.; Lilja, T.; Mannervik, M., 2006:
Drosophila Reptin and other TIP60 complex components promote generation of silent chromatin

Ditch, L.M.; Shirangi, T.; Pitman, J.L.; Latham, K.L.; Finley, K.D.; Edeen, P.T.; Taylor, B.J.; McKeown, M., 2004:
Drosophila retained/dead ringer is necessary for neuronal pathfinding, female receptivity and repression of fruitless independent male courtship behaviors

Ni, J-Quan.; Liu, L-Ping.; Hess, D.; Rietdorf, J.; Sun, F-Lin., 2006:
Drosophila ribosomal proteins are associated with linker histone H1 and suppress gene transcription

Kreisköther, N.; Reichert, N.; Buttgereit, D.; Hertenstein, A.; Fischbach, K-Friedrich.; Renkawitz-Pohl, R., 2006:
Drosophila rolling pebbles colocalises and putatively interacts with alpha-Actinin and the Sls isoform Zormin in the Z-discs of the sarcomere and with Dumbfounded/Kirre, alpha-Actinin and Zormin in the terminal Z-discs

Tsacas, Leonidas, 2004:
Drosophila s. str. acelidota n. sp. et nouveau complexe afrotropical apparente au complexe Acrostigma (Diptera, Drosophilidae)

Osterwalder, T.; Kuhnen, A.; Leiserson, W.M.; Kim, Y-Seung.; Keshishian, H., 2004:
Drosophila serpin 4 functions as a neuroserpin-like inhibitor of subtilisin-like proprotein convertases

Peng, J.; Zipperlen, P.; Kubli, E., 2005:
Drosophila sex-peptide stimulates female innate immune system after mating via the Toll and Imd pathways

Lee, K-Sun.; You, K-Hee.; Choo, J-Kil.; Han, Y-Mahn.; Yu, K., 2004:
Drosophila short neuropeptide F regulates food intake and body size

Casso, D.J.; Tanda, S.; Biehs, B.; Martoglio, B.; Kornberg, T.B., 2005:
Drosophila signal peptide peptidase is an essential protease for larval development

Ballard, J.William.O., 2005:
Drosophila simulans as a novel model for studying mitochondrial metabolism and aging

Riedl, C.A.L.; Neal, S.J.; Robichon, A.; Westwood, J.Timothy.; Sokolowski, M.B., 2005:
Drosophila soluble guanylyl cyclase mutants exhibit increased foraging locomotion: behavioral and genomic investigations

Sherwood, N.Tang.; Sun, Q.; Xue, M.; Zhang, B.; Zinn, K., 2004:
Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function

Coulson, M.; Robert, S.; Saint, R., 2005:
Drosophila starvin encodes a tissue-specific BAG-domain protein required for larval food uptake

Lanzotti, D.J.; Kupsco, J.M.; Yang, X-Cui.; Dominski, Z.; Marzluff, W.F.; Duronio, R.J., 2004:
Drosophila stem-loop binding protein intracellular localization is mediated by phosphorylation and is required for cell cycle-regulated histone mRNA expression

Loewen, C.A.; Royer, S.M.; Reist, N.E., 2006:
Drosophila synaptotagmin I null mutants show severe alterations in vesicle populations but calcium-binding motif mutants do not

True, J.R.; Yeh, S-Dan.; Hovemann, B.T.; Kemme, T.; Meinertzhagen, I.A.; Edwards, T.N.; Liou, S-Ren.; Han, Q.; Li, J., 2005:
Drosophila tan encodes a novel hydrolase required in pigmentation and vision

Zhang, Y.; Billington, C.J.; Pan, D.; Neufeld, T.P., 2005:
Drosophila target of rapamycin kinase functions as a multimer

Secombe, J.; Parkhurst, S.M., 2004:
Drosophila Topors is a RING finger-containing protein that functions as a ubiquitin-protein isopeptide ligase for the hairy basic helix-loop-helix repressor protein

Thomson, T.; Lasko, P., 2004:
Drosophila tudor is essential for polar granule assembly and pole cell specification, but not for posterior patterning

Fritsch, C.; Ploeger, G.; Arndt-Jovin, D.J., 2006:
Drosophila under the lens: imaging from chromosomes to whole embryos

Han, M.; Park, D.; Vanderzalm, P.J.; Mains, R.E.; Eipper, B.A.; Taghert, P.H., 2004:
Drosophila uses two distinct neuropeptide amidating enzymes, dPAL1 and dPAL2

Cavey, M.; Hijal, S.; Zhang, X.; Suter, B., 2005:
Drosophila valois encodes a divergent WD protein that is required for Vasa localization and Oskar protein accumulation

Bier, E.; Bodmer, R., 2004:
Drosophila, an emerging model for cardiac disease

Vodovar, N.; Acosta, C.; Lemaitre, B.; Boccard, Fédéric., 2004:
Drosophila: a polyvalent model to decipher host-pathogen interactions

Beppu, Katsura, 2005:
Drosophilid faunas in the Akasaka Imperial Gardens and the Tokiwamatsu Imperial Villa, Tokyo

Guido, M.; Romualdi, D.; Giuliani, M.; Suriano, R.; Selvaggi, L.; Apa, R.; Lanzone, A., 2004:
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study

Czeslick, E.G.; Nestler, F.; Simm, A.; Struppert, A.; Sablotzki, A., 2005:
Drotrecogin alfa (activated) does not affect intracellular production of interleukin-6 and tumor necrosis factor-alpha in endotoxin-stimulated human monocytes

Rice, T.W.; Bernard, G.R., 2004:
Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock

Brueckmann, M.; Hoffmann, U.; Dvortsak, E.; Lang, S.; Kaden, J.J.; Borggrefe, M.; Haase, K.K., 2004:
Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis

Albuali, W.H.; Singh, R.N.; Fraser, D.D.; Scott, L.A.; Kornecki, A., 2005:
Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure

Koestenberger, M.; Cvirn, G.; Gallistl, S.; Muntean, W., 2004:
Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time

Frommhold, D.; Birle, A.; Linderkamp, O.; Zilow, E.; Pöschl, J., 2005:
Drotrecogin alpha (activated) in neonatal septic shock

Blanco, B., C.; Carrera-Hueso, J.; Poquet-Jornet, J.E.; Martin-Conde, J.A.; Carrera-Hueso, F.J., 2005:
Drotrecogina alfa

Aasamaa, K.; Sober, A.; Hartung, W.; Niinemets, U., 2004:
Drought acclimation of two deciduous tree species of different layers in a temperate forest canopy

Hessl, A.E.; Mckenzie, D.; Schellhaas, R., 2004:
Drought and Pacific Decadal Oscillation linked to fire occurrence in the inland Pacific Northwest

Odebrecht, C.; Abreu, P.; Moller, O.J.; Niencheski, L.; Proenca, L.; Torgan, L., 2005:
Drought effects on pelagic properties in the shallow and turbid patos lagoon, Brazil

Yurkonis, K., A.; Meiners, S., J., 2006:
Drought impacts and recovery are driven by local variation in species turnover

Singh, A.K.; Sing, J.; Reddy, K.K.; Singh, R., 2003:
Drought proofing mechnism in Mahi command area through linear programming model - A case study

Castillo, E.-Guttierez; Tuong, T.-Phuc; Singh, U.; Inubushi, K.; Padilla, J., 2006:
Drought response of dry-seeded rice to water stress timing and N-fertilizer rates and sources

Adams, H.D.; Kolb, T.E., 2004:
Drought responses of conifers in ecotone forests of northern Arizona: tree ring growth and leaf sigma13C

Staley, J.-T.M.rtimer, S.-R.M.sters, G.-J.M.recroft, M.-D.B.own, V.-K.T.ylor, M., E., 2006:
Drought stress differentially affects leaf-mining species

Liu, F.; Jensen, C.R.; Andersen, M.N., 2004:
Drought stress effect on carbohydrate concentration in soybean leaves and pods during early reproductive development: Its implication in altering pod set

Oya, T.; Nepomuceno, A.L.ma; Neumaier, N.; Farias, J.R.nato Boucas; Tobita, S.; Ito, O., 2004:
Drought tolerance characteristics of Brazilian soybean cultivars - Evaluation and characterization of drought tolerance of various Brazilian soybean cultivars in the field

Zeng, H.; Zhong, Y.; Luo, L., 2006:
Drought tolerance genes in rice

Balsamo, R.A.; Willigen, C.Vander.; Bauer, A.M.; Farrant, J., 2006:
Drought tolerance of selected Eragrostis species correlates with leaf tensile properties

Li, Y.; Deng, X-Ping.; Kwak, S-Soo.; Tanaka, K., 2006:
Drought tolerance of transgenic sweet potato expressing both Cu/Zn superoxide dismutase and ascorbate peroxidase

Acuna-Soto, R.; Stahle, D.W.; Therrell, M.D.; Gomez Chavez, S.; Cleaveland, M.K., 2005:
Drought, epidemic disease, and the fall of classic period cultures in Mesoamerica (AD 750-950). Hemorrhagic fevers as a cause of massive population loss

Silliman, B.R.; van de Koppel, J.; Bertness, M.D.; Stanton, L.E.; Mendelssohn, I.A., 2005:
Drought, snails, and large-scale die-off of southern U.S. salt marshes

Shaman, J.; Day, J.F.; Stieglitz, M., 2005:
Drought-induced amplification and epidemic transmission of West Nile virus in southern Florida

Morgan, John, W., 2004:
Drought-related dieback in four subalpine shrub species, Bogong High Plains, Victoria

Gadgil, S.; Vinayachandran, P.N.; Francis, P.A., 2003:
Droughts of the Indian summer monsoon: Role of clouds over the Indian Ocean

Szabadkai, Görgy.; Simoni, A.Maria.; Chami, M.; Wieckowski, M.R.; Youle, R.J.; Rizzuto, R., 2004:
Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis

Jorge, R., E.; Robinson, R., G.; Ardnt, S., 2004:
Drs. Jorge and Robinson reply

Natarajan, P.; Wang, J.; Hua, Z.; Graham, T.R., 2004:
Drs2p-coupled aminophospholipid translocase activity in yeast Golgi membranes and relationship to in vivo function

Zheng, C.J.; Sun, L.Z.; Han, L.Y.; Ji, Z.L.; Chen, X.; Chen, Y.Z., 2004:
Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research

Shimane, T.; Misago, C., 2004:
Drug Addiction Self-Help Recovery scale (DASH-scale): An approach to the measurement of recovery from drug addiction in self-help program among drug addicts

Gaviraghi, G.; Pellicciari, R., 2004:
Drug Discovery: Back and forward

Stewart, K.D.; Shiroda, M.; James, C.A., 2006 :
Drug Guru: a computer software program for drug design using medicinal chemistry rules

Carpenter, K.M.; Schreiber, E.; Church, S.; McDowell, D., 2005:
Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

Kennedy, J.M.; van Rij, A.M., 2006:
Drug absorption from the small intestine in immediate postoperative patients

Gidal, B.E., 2006:
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs

Silva, O.Alves.; Yonamine, M., 2004:
Drug abuse among workers in Brazilian regions

Nair, M.P.N.; Schwartz, S.A.; Mahajan, S.D.; Tsiao, C.; Chawda, R.P.; Whitney, R.; Don Sykes, B.B.; Hewitt, R., 2004:
Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO

Lin, S.K.ang; Wu, S.H.a; Yang, Y.S.u; Pan, W.H.T., 2003:
Drug addiction-the neurochemical perspective of brain in drug-seeking behavior

Patel, N.C.; Crismon, M.Lynn.; Miller, A.L.; Johnsrud, M.T., 2005:
Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy

Collins, G.B.; McAllister, M.S.; Adury, K., 2006:
Drug adjuncts for treating alcohol dependence

Raiman, J.; Hänninen, K.; Kontturi, Kösti.; Murtomäki, L.; Hirvonen, J., 2003:
Drug adsorption in human skin: a streaming potential study

Bertucci, C.; Bartolini, M.; Gotti, R.; Andrisano, V., 2003:
Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

Kennedy, J.; Coyne, J.; Sclar, D., 2004:
Drug affordability and prescription noncompliance in the United States: 1997-2002

Greenberger, Paul, A., 2006:
Drug allergy

Walsh, J.Michael.; Flegel, R.; Atkins, R.; Cangianelli, L.A.; Cooper, C.; Welsh, C.; Kerns, T.J., 2005:
Drug and alcohol use among drivers admitted to a Level-1 trauma center

Margolese, H.C.; Malchy, L.; Negrete, J.Carlos.; Tempier, R.; Gill, K., 2004:
Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

Tardiff, A.Kenneth.J.; Wallace, Z.; Tracy, M.; Piper, T.Markham.; Vlahov, D.; Galea, S., 2005:
Drug and alcohol use as determinants of New York City homicide trends from 1990 to 1998

Furr-Holden, D.; Voas, R.B.; Kelley-Baker, T.; Miller, B., 2006:
Drug and alcohol-impaired driving among electronic music dance event attendees

Ho, R.H.; Tirona, R.G.; Leake, B.F.; Glaeser, H.; Lee, W.; Lemke, C.J.; Wang, Y.; Kim, R.B., 2006:
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics

Reiffel, J.A., 2005:
Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era

X.H.ng Rong; L.X.e Ning; Chen Wei Li, 2003 :
Drug approaches to treatment for human immunodeficiency virus infection

Saitoh, Yusuke; Watari, Jiro; Fujiya, Mikihiro; E.A., 2000:
Drug associated enterocolitis: Causative drugs and pathogenesis

Perry, M.; Stansfeld, P.J.; Leaney, J.; Wood, C.; de Groot, M.J.; Leishman, D.; Sutcliffe, M.J.; Mitcheson, J.S., 2005:
Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs

Scholz, E.P.; Zitron, E.; Kiesecker, C.; Lueck, S.; Kathöfer, S.; Thomas, D.; Weretka, S.; Peth, S.; Kreye, V.A.W.; Schoels, W.; Katus, H.A.; Kiehn, J.; Karle, C.A., 2003:
Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine

Ascoli, G.A.; Domenici, E.; Bertucci, C., 2006:
Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism

Li, J.; Xiao, H.; Li, J.; Zhong, Y., 2004:
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers

Himmel, W.; Kochen, M.M.; Sorns, U.; Hummers-Pradier, E., 2004:
Drug changes at the interface between primary and secondary care

Loboz, K.K.; Shenfield, G.M., 2005:
Drug combinations and impaired renal function -- the 'triple whammy'

Mayor, S., 2005:
Drug companies agree to make clinical trial results public

Cole, J.Alexander.; Norman, H.; Weatherby, L.B.; Walker, A.M., 2006:
Drug copayment and adherence in chronic heart failure: effect on cost and outcomes

Vossius, C.; Gjerstad, M.; Baas, H.; Larsen, J.P., 2006:
Drug costs for patients with Parkinson's disease in two different European countries

Hyland, A.; Bradford, D.; Gitchell, J., 2005:
Drug counselor report of adolescents abuse of nicotine replacement therapy

Matricardi, P.; Onorati, I.; Coviello, T.; Alhaique, F., 2006:
Drug delivery matrices based on scleroglucan/alginate/borax gels

Donnelly, R.F.; McCarron, P.A.; Woolfson, A.David., 2005:
Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy

Lochmann, D.; Jauk, E.; Zimmer, A., 2004:
Drug delivery of oligonucleotides by peptides

Liu, X-Ming.; Reinhardt, R.A.; Wang, D., 2006:
Drug delivery strategies for common orofacial diseases

Ohki, Kazuo, 2006:
Drug delivery system (DDS) by use of Liposomes

Yoo, J-Wook.; Lee, C.H., 2006:
Drug delivery systems for hormone therapy

Ameller, T.; Legrand, P.; Marsaud, Véronique.; Renoir, J-Michel., 2004:
Drug delivery systems for oestrogenic hormones and antagonists: the need for selective targeting in estradiol-dependent cancers

Allen, T.M.; Cullis, P.R., 2004:
Drug delivery systems: entering the mainstream

Simó, C.; Cifuentes, A.; Gallardo, A., 2003:
Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

Serafini, S.; Rossi, L.; Antonelli, A.; Fraternale, A.; Cerasi, A.; Crinelli, R.; Chiarantini, L.; Schiavano, G.F.; Magnani, M., 2004:
Drug delivery through phagocytosis of red blood cells

Lee, S-Bumm.; Geroski, D.H.; Prausnitz, M.R.; Edelhauser, H.F., 2004:
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems

Vauthier, C.; Dubernet, C.; Chauvierre, C.; Brigger, I.; Couvreur, P., 2003:
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles

Lee, T.Wai-Yip.; Robinson, J.R., 2004:
Drug delivery to the posterior segment of the eye II: development and validation of a simple pharmacokinetic model for subconjunctival injection

Lee, T.Wai-Yip.; Robinson, J.R., 2004:
Drug delivery to the posterior segment of the eye III: the effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection

Reddy, L.Harivardhan., 2005:
Drug delivery to tumours: recent strategies

Gerrits, M.A.F.M.; Lesscher, H.B.M.; van Ree, J.M., 2003:
Drug dependence and the endogenous opioid system

Reed, P.L.; Storr, C.L.; Anthony, J.C., 2006:
Drug dependence enviromics: job strain in the work environment and risk of becoming drug-dependent

Yamada, K.; Nagai, T.; Nabeshima, T., 2005:
Drug dependence, synaptic plasticity, and tissue plasminogen activator

Fujii, H.; Narita, M.; Mizoguchi, H.; Murachi, M.; Tanaka, T.; Kawai, K.; Tseng, L.F.; Nagase, H., 2004:
Drug design and synthesis of epsilon opioid receptor agonist: 17-(cyclopropylmethyl)-4,5alpha-epoxy-3,6beta-dihydroxy-6,14-endoethenomorphinan-7alpha-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative epsilon opioid receptor

Bureeva, S.; Andia-Pravdivy, J.; Kaplun, A., 2005:
Drug design using the example of the complement system inhibitors' development

Dikici, E.; Deo, S.K.; Daunert, S., 2003:
Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner

Freimann, S.; Ben-Ami, I.; Hirsh, L.; Dantes, A.; Halperin, R.; Amsterdam, A., 2004:
Drug development for ovarian hyper-stimulation and anti-cancer treatment: blocking of gonadotropin signaling for epiregulin and amphiregulin biosynthesis

Kummar, S.; Gutierrez, M.; Doroshow, J.H.; Murgo, A.J., 2006:
Drug development in oncology: classical cytotoxics and molecularly targeted agents

Triggle, David, J., 2004:
Drug development in the 21st century: Medicines, man and receptors

Smith, J.D.; Chakrabarti, E.; Levin-Allerhand, J.A., 2004:
Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease

Barsby, T., 2005:
Drug discovery and sea hares: bigger is better

Gullo, V.P.; McAlpine, J.; Lam, K.S.; Baker, D.; Petersen, F., 2006:
Drug discovery from natural products

Cuatrecasas, P., 2006:
Drug discovery in jeopardy

Workman, P., 2004:
Drug discovery strategies: Technologies to accelerate translation from target to drug

Davies, S., L.; Silvestre, J., S.; Guitart, X., 2005:
Drug discovery targets: 5-HT6 receptor

Ségalat, L., 2006:
Drug discovery: here comes the worm

Sams-Dodd, F., 2006:
Drug discovery: selecting the optimal approach

Zakharova, E.S.; Danysz, W.; Bespalov, A.Y., 2005:
Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats

Czoty, P.W.; Ramanathan, C.R.; Mutschler, N.H.; Makriyannis, A.; Bergman, J., 2004:
Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors

Murav'ev, I.V.; Murav'eva, L.A., 2005:
Drug disease: is it iatrogeny?

Källén, A.; Thorsson, L., 2003:
Drug disposition analysis: a comparison between budesonide and fluticasone

Srinivas, N.R. , 2006:
Drug disposition of chiral and achiral drug substrates metabolized by cytochrome P450 2D6 isozyme: case studies, analytical perspectives and developmental implications

Hawkins, M.G.; Karriker, M.J.; Wiebe, V.; Taylor, I.T.; Kass, P.H., 2006:
Drug distribution and stability in extemporaneous preparations of meloxicam and carprofen after dilution and suspension at two storage temperatures

Li-Yong; Liu-Bin-Wei; Du-Wen-Li; Song-Zhen-Chuan; Zhao-Qun; Fan-Li-Qiao; Yang-Jin-Qiang; Li-Qi-Jun; Wang-Ming-Xia; Jiao-Zhi-Kai; Zhang-Zhi-Dong, 2004:
Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome

van Dijk, E.A.; Drabbe, N.R.G.; Kruijtbosch, M.; De Smet, P.A.G.M., 2006:
Drug dosage adjustments according to renal function at hospital discharge

Daschner, M., 2005:
Drug dosage in children with reduced renal function

Yee, T.; Perantie, D.C.; Dhanani, N.; Brown, E.Sherwood., 2004:
Drug dreams in outpatients with bipolar disorder and cocaine dependence

Darke, S.; Kelly, E.; Ross, J., 2004:
Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions

Bachmeier, C.J.; Trickler, W.J.; Miller, D.W., 2004:
Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF

Presbitero, P.; Boccuzzi, G.; Pagnotta, P., 2005:
Drug eluting stents in acute myocardial infarction

Roiron, C.; Sanchez, P.; Bouzamondo, A.; Lechat, P.; Montalescot, G., 2005 :
Drug eluting stents: an updated meta-analysis of randomised controlled trials

Chattopadhyay, P.; Huff, R.; Shekunov, B.Y., 2006:
Drug encapsulation using supercritical fluid extraction of emulsions

Yilmaz, E.; Bengisu, M., 2005:
Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior

Rallis, E.; Balatsouras, D.G.; Kouskoukis, C.; Verros, C.; Homsioglou, E., 2005:
Drug eruptions in children with ENT infections

Lazar, C.; Kluczyk, A.; Kiyota, T.; Konishi, Y., 2004:
Drug evolution concept in drug design: 1. Hybridization method

Hogarth, L.; Dickinson, A.; Hutton, S.B.; Elbers, N.; Duka, T., 2006:
Drug expectancy is necessary for stimulus control of human attention, instrumental drug-seeking behaviour and subjective pleasure

Czeizel, A.E., 2004:
Drug exposure in pregnant women

Re, M.C.; Bon, I.; Monari, P.; Gorini, R.; Schiavone, P.; Gibellini, D.; L.P.aca, M., 2003:
Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance

Wakonigg, G.; Sturm, K.; Saria, A.; Zernig, G., 2004:
Drug history overrides opioid reinforcement in a rat runway procedure

Kim, C-Woo.; Choi, G-Seong.; Yun, C-Ho.; Kim, D-In., 2006:
Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome

Shinar, D.; Schechtman, E., 2005:
Drug identification performance on the basis of observable signs and symptoms

Yap, Y.Guan.; Camm, A.John., 2003:
Drug induced QT prolongation and torsades de pointes

Chazan, B.; Weiss, A.; Weiner, Z.; Rimbrot, S.; Raz, R., 2003:
Drug induced aseptic meningitis due to diclofenac

Latour, P.; Biraben, A.; Polard, E.; Bentué-Ferrer, Dèle.; Beauplet, A.; Tribut, O.; Allain, Hé., 2004:
Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?

Bazlul Karim, A.S.M.; Hoque, M.Shafiqul.; Kamal, M., 2004:
Drug induced hepatic focal nodular hyperplasia

Hirose, Genjiro, 2006:
Drug induced parkinsonism - A review

Masruha, M.R.; Marques, C.M.; Vilanova, L.C.P.; de Seixas Alves, M.T.; Peres, M.F.P.; Rodrigues, M.G., 2005:
Drug induced pseudolymphoma secondary to ethosuximide

Singh, J., 2004:
Drug info zone

Crank, Mariana, Y., 2005:
Drug information services: Hospital pharmacists' utilisation and opinion

Bouhnik, A-Déborah.; Carrieri, M.Patrizia.; Rey, D.; Spire, B.; Gastaut, J-Albert.; Gallais, Hé.; Obadia, Y., 2004:
Drug injection cessation among HIV-infected injecting drug users

Booth, R.E.; Kennedy, J.; Brewster, T.; Semerik, O., 2004:
Drug injectors and dealers in Odessa, Ukraine

Aadil, N.; Houti, I.E.; Moussamih, S., 2004:
Drug intake during Ramadan

El Maghraby, G.M.M.; Williams, A.C.; Barry, B.W., 2005:
Drug interaction and location in liposomes: correlation with polar surface areas

Yildirim, Y.; Ozyilkan, O.; Akcali, Z.; Basturk, B., 2006:
Drug interaction between capecitabine and warfarin: a case report and review of the literature

Onoda, S.; Mitsufuji, H.; Yanase, N.; Ryuge, S.; Kato, E.; Wada, M.; Ishii, K.; Hagiri, S.; Yamamoto, M.; Yokoba, M.; Yanaihara, T.; Kuboto, M.; Takada, N.; Katagiri, M.; Abe, T.; Tanaka, N.; Kobayashi, H.; Masuda, N., 2005:
Drug interaction between gefitinib and warfarin

Roblin, X.; Serre-Debeauvais, F.; Phelip, J-M.; Bessard, G.; Bonaz, B., 2003:
Drug interaction between infliximab and azathioprine in patients with Crohn's disease

Okuda, T.; Ito, Y.; Nakagawa, N.; Hishinuma, T.; Tsukamoto, H.; Iwabuchi, K.; Watanabe, T.; Kitaichi, K.; Goto, J.; Yanai, K., 2004:
Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats

Kuypers, D.R.J.; Verleden, G.; Naesens, M.; Vanrenterghem, Y., 2005:
Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase

Wauters, J-Pierre.; Uehlinger, D.; Marti, H-Peter., 2004:
Drug interaction between sevelamer and cyclosporin

Fleuren, H.W.H.A.; Kho, Y.; Schuurmans, M.M.J.; Vollaard, E.J., 2005:
Drug interaction between sevelamer and furosemide

Depta, J.Paul.Heribert.; Altznauer, F.; Gamerdinger, K.; Burkhart, C.; Weltzien, H.Ulrich.; Pichler, W.Joseph., 2004:
Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity

Alisky, J.M.; Chertkova, E.L.; Iczkowski, K.A., 2006:
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis

Gasse, C.; Hollowell, J.; Meier, C.R.; Haefeli, W.E., 2005:
Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

Reimers, A.; Skogvoll, E.; Sund, J.Kutschera.; Spigset, O., 2005:
Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service

Clark, D.B.; Andrus, M.R.; Byrd, D.C., 2006:
Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature

Hersh, E.V.; Moore, P.A., 2004:
Drug interactions in dentistry: the importance of knowing your CYPs

Bergk, V.; Gasse, C.; Rothenbacher, D.; Loew, M.; Brenner, H.; Haefeli, W.E., 2004:
Drug interactions in primary care: impact of a new algorithm on risk determination

Huang, S-Mei.; Hall, S.D.; Watkins, P.; Love, L.A.; Serabjit-Singh, C.; Betz, J.M.; Hoffman, F.Ann.; Honig, P.; Coates, P.M.; Bull, J.; Chen, S.T.; Kearns, G.L.; Murray, M.D., 2004:
Drug interactions with herbal products and grapefruit juice: a conference report

Tirkkonen, T.; Laine, K., 2004:
Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients

Berkowitz, B.A.; Roberts, R.; Luan, H.; Peysakhov, J.; Knoerzer, D.L.; Connor, J.R.; Hohman, T.C., 2005:
Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy

Murdoch, J.A.C.; Lane, J.; Goldstein, D.H., 2004:
Drug labelling and a near miss in the labour suite

Lewis, A.L.; Willis, S.L.; Small, S.A.; Hunt, S.R.; O'byrne, V.; Stratford, P.W., 2004:
Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo

Abdekhodaie, M.J.; Wu, X.Yu., 2006:
Drug loading onto ion-exchange microspheres: modeling study and experimental verification

Stumpf, W.E., 2004:
Drug localization and targeting with receptor microscopic autoradiography

Ponsoda, X.; Donato, M.Teresa.; Perez-Cataldo, G.; Gómez-Lechón, M.José.; Castell, Jé.V., 2004:
Drug metabolism by cultured human hepatocytes: how far are we from the in vivo reality?

Kermode-Scott, B., 2004:
Drug misuse in Canada has increased in the past decade

Gerada, C., 2005:
Drug misuse: a review of treatments

Hägerström, H.; Strømme, M.; Edsman, K., 2005:
Drug molecules as probes for studying the compatibility between gels and mucous tissue with dielectric spectroscopy

Lee, J., 2003:
Drug nano- and microparticles processed into solid dosage forms: physical properties

Keck, C.M.; Müller, R.H., 2005:
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation

Moribe, K.; Pongpeerapat, A.; Tozuka, Y.; Yamamoto, K., 2006:
Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures

Bossert, J.M.; Shaham, Y., 2004:
Drug onset cues, conditioned withdrawal, and drug relapse: comment on McDonald and Siegel (2004)

Engvall, C.; Lundahl, P., 2004:
Drug partition chromatography on immobilized porcine intestinal brush border membranes

Barbaud, A., 2005:
Drug patch testing in systemic cutaneous drug allergy

Oldman, M.; Moore, D.; Collins, S., 2004:
Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction

Flaten, Gøril.Eide.; Dhanikula, A.Babu.; Luthman, K.; Brandl, M., 2005:
Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion

Flaten, Gøril.Eide.; Bunjes, H.; Luthman, K.; Brandl, M., 2006:
Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes

Mälkiä, A.; Murtomäki, L.; Urtti, A.; Kontturi, Kösti., 2004:
Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties

Suvarna, R.; Pirmohamed, M.; Henderson, L., 2003:
Drug point: Possible interaction between warfarin and cranberry juice

Waage, I.-Marie; Gedde-Dahl, A., 2003:
Drug points: Pulmonary embolism possibly associated with olanzapine treatment

Morton, A.; Muir, J.; Lim, D., 2004:
Drug points: Rash and acute nephritic syndrome due to candesartan

Shotar, Ali, M., 2005:
Drug poisoning in childhood

Marlowe, D.B.; Elwork, A.; Festinger, D.S.; McLellan, A.Thomas., 2003:
Drug policy by popular referendum: This, too, shall pass

Maseeh, A.; Dadhich, A.P.; Agarwal, A.K., 2004:
Drug prescribing pattern in patients admitted with tuberculosis in a tertiary care hospital

Vedsted, P.; Sørensen, H.Toft.; Mortensen, J.Tølbøll., 2004:
Drug prescription for adult frequent attenders in Danish general practice: a population-based study

Egen-Lappe, V.; Hasford, J., 2004:
Drug prescription in pregnancy: analysis of a large statutory sickness fund population

Bongard, V.; Grenier, O.; Ferrières, J.; Danchin, N.; Cantet, C.; Amelineau, E.; Cambou, J-Pierre., 2004:
Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

Gorniak, J.M.; Jenkins, A.J.; Felo, J.A.; Balraj, E., 2005:
Drug prevalence in drowning deaths in Cuyahoga County, Ohio: a ten-year retrospective study

Messaad, D.; Sahla, H.; Benahmed, S.; Godard, P.; Bousquet, J.; Demoly, P., 2004:
Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction

Khabriyev, R.U.; Yagudina, R.I., 2005:
Drug quality on the Russian pharmaceutical market: general trends

DeMaria, A.N., 2004:
Drug reimportation: sitting in the middle

Watson, R., 2004:
Drug related deaths in Europe are falling

Souchet, E.; Lapeyre-Mestre, M.; Montastruc, J-Louis., 2004:
Drug related falls: a study in the French Pharmacovigilance database

Friedrich, I.; Reichl, S.; Müller-Goymann, C.C., 2005:
Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS)

Matsumoto, A.; Matsukawa, Y.; Suzuki, T.; Yoshino, H., 2005:
Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide)

Lou, X.; Munro, S.; Wang, S., 2004:
Drug release characteristics of phase separation pHEMA sponge materials

Pitarresi, G.; Pierro, P.; Giammona, G.; Iemma, F.; Muzzalupo, R.; Picci, N., 2004:
Drug release from alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide-based microparticles

Llabot, J.M.; Manzo, R.H.; Allemandi, D.A., 2004:
Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system

Cornejo-Bravo, J.M.; Flores-Guillen, M.E.; Lugo-Medina, E.; Licea-Claverie, A., 2005:
Drug release from complexes with a series of poly(carboxyalkyl methacrylates), a new class of weak polyelectrolytes

Tada, D.; Tanabe, T.; Tachibana, A.; Yamauchi, K., 2005:
Drug release from hydrogel containing albumin as crosslinker

Wang, L.; Venkatraman, S.; Kleiner, L., 2004:
Drug release from injectable depots: two different in vitro mechanisms

Guse, C.; Koennings, S.; Kreye, F.; Siepmann, F.; Goepferich, A.; Siepmann, J., 2006:
Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms

Kondyurin, A.V.; Maitz, M.F.; Romanova, V.A.; Begishev, V.P.; Kondyurina, I.V.; Guenzel, R., 2004:
Drug release from polyureaurethane coating modified by plasma immersion ion implantation

Tunón, A.; Börjesson, E.; Frenning, Göran.; Alderborn, Göran., 2003:
Drug release from reservoir pellets compacted with some excipients of different physical properties

Tuovinen, L.; Peltonen, S.; Järvinen, K., 2003:
Drug release from starch-acetate films

Tuovinen, L.; Peltonen, S.; Liikola, M.; Hotakainen, M.; Lahtela-Kakkonen, M.; Poso, A.; Järvinen, K., 2004:
Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase

Kiortsis, S.; Kachrimanis, K.; Broussali, T.; Malamataris, S., 2004:
Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component

Kim, I-Sook.; Oh, I-Joon., 2005:
Drug release from the enzyme-degradable and pH-sensitive hydrogel composed of glycidyl methacrylate dextran and poly(acrylic acid)

Yoo, M.Kyong.; Choi, H.Kyun.; Kim, T.Hee.; Choi, Y.Jaie.; Akaike, T.; Shirakawa, M.; Cho, C.Su., 2005:
Drug release from xyloglucan beads coated with Eudragit for oral drug delivery

Ferrero, C.; Bravo, I.; Jiménez-Castellanos, M.R., 2003:
Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity

Zhang, L.; Chen, D-wei.; Gao, Z-bin., 2006:
Drug release mechanism of famotidine time-controlled release pellets

Abu-Bakr, M.; Khatun, S.; Islam, M.-Amirul, 2004:
Drug release profile of malic acid-phthalic acid butane 1,4-diol copolyester

Charrois, G.J.R.; Allen, T.M., 2004:
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

Ongerth, J.E.; Khan, S., 2004:
Drug residuals: How xenobiotics can affect water supply sources

Shafer, R.W.; Schapiro, J.M., 2005:
Drug resistance and antiretroviral drug development

Casanovas, O.; Hicklin, D.J.; Bergers, G.; Hanahan, D., 2005:
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Smith, R.J.; Wahl, L.M., 2005:
Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects

Komarova, N.L.; Wodarz, D., 2005:
Drug resistance in cancer: principles of emergence and prevention

Saeki, T.; Tsuruo, T.; Sato, W.; Nishikawsa, K., 2005:
Drug resistance in chemotherapy for breast cancer

Schmidt, D.; Löscher, W., 2005:
Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

Boost, M.; Lai, L.; O'Donoghue, M., 2004:
Drug resistance in fecal enterococci in Hong Kong

Ebrahim, G.J., 2007:
Drug resistance in tuberculosis

Paramasivan, C.N.; Venkataraman, P., 2004:
Drug resistance in tuberculosis in India

Larbalestier, N.; Mullen, J.; O'Shea, S.; Cottam, F.; Sabin, C.A.; Chrystie, I.L.; Welch, J.; Zuckerman, M.; Hay, P.; Rice, P.; Taylor, G.P.; de Ruiter, A., 2003:
Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission

Torti, C.; Quiros-Roldan, E.; Monno, L.; Patroni, A.; Saracino, A.; Angarano, G.; Tinelli, C.; Lo Caputo, S.; Tirelli, V.; Mazzotta, F.; Carosi, G., 2004:
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

Crespan, E.; Locatelli, G.A.; Cancio, R.; Hübscher, U.; Spadari, S.; Maga, G., 2004:
Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz

Anokhin, V.A.; Khaliullina, S.V.; Khasanova, E.E.; Nikolaeva, I.V.; Malysheva, L.M.; Gerasimova, E.S., 2005:
Drug resistance of Esherichia coli in asymptomatic bacteriuria and bacteriolactia

Bandyopadhyay, P.; Meher, B.R., 2006:
Drug resistance of HIV-1 protease against JE-2147: I47V mutation investigated by molecular dynamics simulation

Liu, C-Eng.; Chen, C.-Hua.; Hsiao, J-Hua.; Young, T-Guang.; Tsay, R-Wen.; Fung, C-Phone., 2004:
Drug resistance of Mycobacterium tuberculosis complex in central Taiwan

Nian Hua; Wang Qian; Sun, Y.H.ng; Ding, L.P.ng, 2004:
Drug resistance of common bacteria isolated from blood and bone marrow

Yang-Ri-Dong; Li-Xiao-Dong; Tao-Xiao-Hua; Cai-Chuan-Chuan; Zhang-Wen-Jun; Lin-Shi-Ying; Chen-Zhan-Lin, 2004:
Drug resistance of fungi in EPS of patients with prostatitis post-STD

Liaw, Y-Shuang.; Hsueh, P-Ren.; Yu, C-Jen.; Wang, S-Kuang.; Yang, P-Chyr.; Luh, K-Tay., 2004:
Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002

Pereira, M.; Tripathy, S.; Inamdar, V.; Ramesh, K.; Bhavsar, M.; Date, A.; Iyyer, R.; Acchammachary, A.; Mehendale, S.; Risbud, A., 2005:
Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India

Quan, Y.; Brenner, B.G.; Marlink, R.G.; Essex, M.; Kurimura, T.; Wainberg, M.A., 2003:
Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C

Gómez-Carrillo, M.; Quarleri, J.F.; Rubio, A.E.; Carobene, M.G.; Dilernia, Dío.; Carr, J.K.; Salomón, H., 2004:
Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form

Hinrichs, J.W.J.; Klappe, K.; van Riezen, M.; Kok, J.W., 2005:
Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains

Waller, P.C.; Evans, S.J.W.; Beard, K., 2006:
Drug safety and the media

Juillerat, P.; Felley, C.; Mottet, C.; Froehlich, F.; Vader, J-Paul.; Burnand, B.; Gonvers, J-Jacques.; Michetti, P., 2005:
Drug safety in the treatment of Crohn's disease

Lu, N.T.; Taylor, B.G., 2005:
Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories

Liu, A.; Cao, H.; Du, G., 2005:
Drug screening for influenza neuraminidase inhibitors

Schwettmann, L.; Külpmann, W-Rüdiger.; Vidal, C., 2006:
Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study

Altun, Z.; Blomberg, L., G.; Jagerdeo, E.; Abdel-Rehim, M., 2006:
Drug screening using microextraction in a packed syringe (MEPS)/mass spectrometry utilizing monolithic-, polymer-, and silica-based sorbents

Vanderschuren, L.J.M.J.; Everitt, B.J., 2004:
Drug seeking becomes compulsive after prolonged cocaine self-administration

Vukmir, R.B., 2004:
Drug seeking behavior

Tomson, Törn., 2004:
Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated?

Matsuo, Y.; Kakimaru, A.; Miyazaki, D.; Hatta, S.; Inoue, Y.; Fujiwara, H., 2005:
Drug sensitivity and patients' background of isolated microorganisms in our institution

Attlmayr, B.; Kollaritsch, H.; Wernsdorfer, W.H.; Miller, R.S.; Sirichaisinthop, J.; Noedl, H., 2006:
Drug sensitivity of Plasmodium falciparum along the Thai-Myanmar border using the new field-deployable HRP2 in vitro assay

Shman, T.V.; Belevtsev, M.B.; Buglova, S.Y., 2005:
Drug sensitivity of tumor cells in varieties of acute childhood leukemia

Isonishi, S.; Niimi, S.; Sasaki, H.; Ochiai, K.; Yasuda, M.; Tanaka, T., 2004:
Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer

Barbaud, A.; Trechot, P.; Weber-Muller, F.; Ulrich, G.; Commun, N.; Schmutz, J.L., 2004:
Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins

McDermott, Sán.D.; Power, J.D., 2005:
Drug smuggling using clothing impregnated with cocaine

Kaukonen, A.Marie.; Boyd, B.J.; Porter, C.J.H.; Charman, W.N., 2004:
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations

Kaukonen, A.Marie.; Boyd, B.J.; Charman, W.N.; Porter, C.J.H., 2004:
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids

Müller, J.; Lips, K.S.; Metzner, L.; Neubert, R.H.H.; Koepsell, H.; Brandsch, M., 2005:
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)

Linde, L.; Hetland, M.L.; Ostergaard, M., 2006:
Drug survival and reasons for discontinuation of intramuscular methotrexate: a study of 212 consecutive patients switching from oral methotrexate

Ehara, M.; Nguyen, B.M.; Nguyen, D.T.; Toma, C.; Higa, N.; Iwanaga, M., 2004:
Drug susceptibility and its genetic basis in epidemic Vibrio cholerae O1 in Vietnam

Sethi, S.; Sharma, S.; Sharma, S.K.; Meharwal, S.K.; Jindal, S.K.; Sharma, M., 2004:
Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay

Coban, A.Yilmaz.; Birinci, A.; Ekinci, B.; Durupinar, B., 2004:
Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth

Coban, A.Yilmaz.; Birinci, A.; Ekinci, B.; Durupinar, B., 2004:
Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay

Zhao, S.Z.; Wentworth, C.; Burke, T.A.; Makuch, R.W., 2004:
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs

Li, T-Kun.; Barbieri, C.M.; Lin, H-Chin.; Rabson, A.B.; Yang, G.; Fan, Y.; Gaffney, B.L.; Jones, R.A.; Pilch, D.S., 2004:
Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication

Harsha, N.Sree.; Rani, R.H.Shobha., 2006:
Drug targeting to lungs by way of microspheres

Fendrich, M.; Johnson, T.P.; Wislar, J.S.; Hubbell, A., 2004:
Drug test feasibility in a general population household survey

Peters, F.T.; Samyn, N.; Lamers, C.T.J.; Riedel, W.J.; Kraemer, T.; de Boeck, G.; Maurer, H.H., 2005:
Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA

Levy, S.; Harris, S.Kim.; Sherritt, L.; Angulo, M.; Knight, J.R., 2006:
Drug testing of adolescents in ambulatory medicine: physician practices and knowledge

Tallman, M.S.; Gilliland, D.Gary.; Rowe, J.M., 2005:
Drug therapy for acute myeloid leukemia

Kumar, R.; Gautam, G.; Gupta, N.P., 2006:
Drug therapy for idiopathic male infertility: rationale versus evidence

Winocour, Peter, H., 2005:
Drug therapy for prevention of cardiovascular disease - should surrogate measures be abandoned?

Abdulla, R-id., 2005:
Drug therapy in pediatric cardiology and the role of digoxin in pediatric congestive heart failure

Lindenfeld, J.; Miller, G.G.; Shakar, S.F.; Zolty, R.; Lowes, B.D.; Wolfel, E.E.; Mestroni, L.; Page, R.L.; Kobashigawa, J., 2004:
Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs

Lindenfeld, J.; Miller, G.G.; Shakar, S.F.; Zolty, R.; Lowes, B.D.; Wolfel, E.E.; Mestroni, L.; Page, R.L.; Kobashigawa, J., 2004:
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs

Lindenfeld, J.; Page, R.L.; Zolty, R.; Shakar, S.F.; Levi, M.; Lowes, B.; Wolfel, E.E.; Miller, G.G., 2005:
Drug therapy in the heart transplant recipient: Part III: common medical problems

Page, R.L.; Miller, G.G.; Lindenfeld, J., 2005:
Drug therapy in the heart transplant recipient: part IV: drug-drug interactions

Marković, B.Bergman.; Kranjcević, K.; Reiner, Z.; Blazeković, S.Milaković.; Spehar, S.Stojanović., 2005:
Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service

Chen, D-you.; Cao, J.; Zhu, B-po., 2006:
Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old

Howard, P.A.; Cheng, J.W.M.; Crouch, M.A.; Colucci, V.J.; Kalus, J.S.; Spinler, S.A.; Munger, M., 2006:
Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure

McIntyre, J.; Choonara, I., 2004:
Drug toxicity in the neonate

Serra, L.; Doménech, J.; Peppas, N.A., 2006:
Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

Mottier, L.; Alvarez, L.; Ceballos, L.; Lanusse, C., 2006:
Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

Petzinger, E.; Geyer, J., 2006:
Drug transporters in pharmacokinetics

Walsh, J.M.E.; Pignone, M., 2004:
Drug treatment of hyperlipidemia in women

Dai-Yongan; Chen-Tielong; Luo-Mingqi; Et-Al, 2005:
Drug treatment of opportunistic infections in 53 patients with AIDS

Beaulieu, M-D.; Brophy, J.; Jacques, A.; Blais, R.; Battista, R.; Lebeau, R., 2004:
Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial

Bhattacharjee, H.; Carbrey, J.; Rosen, B.P.; Mukhopadhyay, R., 2004:
Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9

Peters, R.J.; Tortolero, S.R.; Addy, R.C.; Markham, C.; Yacoubian, G.S.; Escobar-Chaves, L.S., 2003:
Drug use among Texas alternative school students: findings from Houston's Safer Choices 2 Program

Abdulkarim, A.A.; Mokuolu, O.A.; Adeniyi, A., 2005:
Drug use among adolescents in Ilorin, Nigeria

Schirm, E.; Pedersen, L.; Tobi, H.; Nielsen, G.L.; Sørensen, H.T.; de Jong-van den Berg, L.T.W., 2004:
Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands

Passare, G.; Fastbom, J.; Törring, O.; Viitanen, M., 2004 :
Drug use and increased HbA1c levels in non-diabetic very elderly persons: the Kungsholmen project

Piccoli, G.B.; Soragna, G.; Putaggio, S.; Consiglio, V.; Mezza, E.; Bonetto, A.; Geuna, S., 2006:
Drug use and kidney donation: what are high-risk behaviors today?

Stephen, B., J.; Linsenmeyer, S., M.; Mcguire, S., M., 2005:
Drug use and lifestyle at a Nebraska two-year college

Liu, C.; Li, J.-Heng; Tsay, W.-Ing; Hsu, J., 2005:
Drug use and profile of individuals arrested on drug-related charges in Taiwan

Benotsch, E.G.; Somlai, A.M.; Pinkerton, S.D.; Kelly, J.A.; Ostrovski, D.; Gore-Felton, C.; Kozlov, A.P., 2004:
Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs

Smink, B.E.; Ruiter, B.; Lusthof, K.J.; de Gier, J.J.; Uges, D.R.A.; Egberts, A.C.G., 2005:
Drug use and the severity of a traffic accident

Pilotto, A.; Franceschi, M.; Vitale, D.; Zaninelli, A.; Masotti, G.; Rengo, F., 2005:
Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms

Peretti-Watel, P.; Spire, B.; Lert, F.; Obadia, Y., 2006:
Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003)

Hach, I.; Rentsch, A.; Ruhl, U.E.; Becker, E.S.; Türke, V.; Margraf, Jürgen.; Kirch, W., 2004:
Drug use patterns in young German women and association with mental disorders

Carlson, R.G.; Wang, J.; Falck, R.S.; Siegal, H.A., 2005:
Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis

Inchaurraga, S., 2003:
Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives

Liu, H.; Grusky, O.; Li, X.; Ma, E., 2006:
Drug users: a potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China

Tobi, H.; Scheers, T.; Netjes, K.A.; Mulder, E.J.; de Bildt, A.; Minderaa, R.B., 2005:
Drug utilisation by children and adolescents with mental retardation: a population study

Sanz, E.; Hernández, M.A.; Ratchina, S.; Stratchounsky, L.; Peiré, M.A.; Lapeyre-Mestre, M.; Horen, B.; Kriska, M.; Krajnakova, H.; Momcheva, H.; Encheva, D.; Martínez-Mir, I.; Palop, V., 2004:
Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia)

Ay, P.; Akici, A.; Harmanc, H., 2005:
Drug utilization and potentially inappropriate drug use in elderly residents of a community in Istanbul, Turkey

Zuppa, A.F.; Adamson, P.C.; Mondick, J.T.; Davis, L.A.; Maka, D.A.; Narayan, M.; Nicholson, C.; Patel, D.; Collison, K.R.; Barrett, J.S., 2005:
Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children

Biswal, S.; Mishra, P.; Malhotra, S.; Puri, G.D.; Pandhi, P., 2006:
Drug utilization pattern in the intensive care unit of a tertiary care hospital

Chen, L.C.; Wang, B.R.; Chou, Y.C.; Tien, J.H., 2005:
Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan

Mohanty, M.; Mohapatra, S., 2003 :
Drug utilization pattern of topical ocular antimicrobials in a tertiary care hospital

Pulver, L., K.; Tett, S., E., 2006:
Drug utilization review across jurisdictions - a reality or still a distant dream?

LeLorier, J.; Fitzsimon, C.; Keresteci, M.; Stewart, D.; Lavoie, F., 2003:
Drug utilization review of celecoxib in Ontario

Luo, N.; Koh, Y.; Tan, C.Hoon.; Kua, E.Heok.; Li, S.Chuen., 2004:
Drug utilization review of risperidone for outpatients in a tertiary referral hospital in Singapore

Hallas, J., 2005:
Drug utilization statistics for individual-level pharmacy dispensing data

Daneshtalab, N.; Lewanczuk, R.Z.; Russell, A.S.; Jamali, F., 2006:
Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis

Kearney, B.P.; Sayre, J.R.; Flaherty, J.F.; Chen, S-Shan.; Kaul, S.; Cheng, A.K., 2005:
Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine

Rheeders, M.; Bouwer, Mène.; Goosen, T.C., 2006:
Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine

Kenawi, I.M.; Barsoum, B.N.; Youssef, M.A., 2005:
Drug-drug interaction between diclofenac, cetirizine and ranitidine

Hirano, M.; Maeda, K.; Shitara, Y.; Sugiyama, Y., 2006:
Drug-drug interaction between pitavastatin and various drugs via OATP1B1

Niwa, T.; Shiraga, T.; Takagi, A., 2005:
Drug-drug interaction of antifungal drugs

Sitsen, J.; Maris, F.; Timmer, C., 2001:
Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects

Glintborg, B.; Andersen, S.-Ejdrup; Dalho, K., 2005:
Drug-drug interactions among recently hospitalised patients - frequent but mostly clinically insignificant

Yoshiyama, Y.; Sugiyama, T.; Kanke, M.; Tsuchimoto, K., 2004:
Drug-drug interactions between antiarrhythmic drugs in chick embryos

Williams, J.Andrew.; Hyland, R.; Jones, B.C.; Smith, D.A.; Hurst, S.; Goosen, T.C.; Peterkin, V.; Koup, J.R.; Ball, S.E., 2004:
Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

Furuta, S.; Kamada, E.; Omata, T.; Sugimoto, T.; Kawabata, Y.; Yonezawa, K.; Wu, X.Cheryl.; Kurimoto, T., 2004:
Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338

Fridén, M.; Vanaja, K.; Nandi, V.N., 2006:
Drug-drug interactions of anti-infective drugs: utility of fluorescence cyp inhibition assays in drug discovery

Huang, S-Mei.; Lesko, L.J., 2004:
Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

Cosgrave, J.; Melzi, G.; Biondi-Zoccai, G.G.L.; Airoldi, F.; Chieffo, A.; Sangiorgi, G.M.; Montorfano, M.; Michev, I.; Carlino, M.; Bonizzoni, E.; Colombo, A., 2006:
Drug-eluting stent restenosis the pattern predicts the outcome

Moreno, Rúl.; Fernández, C.; Hernández, R.; Alfonso, F.; Angiolillo, D.J.; Sabaté, M.; Escaned, J.; Bañuelos, C.; Fernández-Ortiz, A.; Macaya, C., 2005:
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

Kaneda, H., 2006:
Drug-eluting stent thrombosis: a pooled analysis

Leon, M.B.; Bakhai, A., 2003:
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future

Pache, Jürgen.; Dibra, A.; Mehilli, J.; Dirschinger, J.; Schömig, A.; Kastrati, A., 2005:
Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial

Finn, A.V.; Palacios, I.F.; Kastrati, A.; Gold, H.K., 2005:
Drug-eluting stents for diabetes mellitus: a rush to judgment?

Schofer, J.; Bode, C.; Silber, S., 2004:
Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies

Abou-Chebl, A.; Bashir, Q.; Yadav, J.S., 2005:
Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up

Moses, J.W.; Stone, G.W.; Nikolsky, E.; Mintz, G.S.; Dangas, G.; Grube, E.; Ellis, S.G.; Lansky, A.J.; Weisz, G.; Fahy, M.; Na, Y.; Russell, M.E.; Donohoe, D.; Leon, M.B.; Mehran, R., 2006:
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials

Pires, N.M.M.; Jukema, J.Wouter.; Daemen, M.J.A.P.; Quax, P.H.A., 2006:
Drug-eluting stents studies in mice: do we need atherosclerosis to study restenosis?

Dobesh, P.P.; Stacy, Z.A.; Ansara, A.J.; Enders, J.M., 2004:
Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease

Bhatia, V.; Bhatia, R.; Dhindsa, M., 2004:
Drug-eluting stents: new era and new concerns

Parry, T.J.; Brosius, R.; Thyagarajan, R.; Carter, D.; Argentieri, D.; Falotico, R.; Siekierka, J., 2005:
Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries

Haery, C.; Sachar, R.; Ellis, S.G., 2004:
Drug-eluting stents: the beginning of the end of restenosis?

Wong, A.; Chan, C., 2004:
Drug-eluting stents: the end of restenosis?

Hill, R.A.; Dündar, Y.; Bakhai, A.; Dickson, R.; Walley, T., 2004:
Drug-eluting stents: an early systematic review to inform policy

Virmani, R.; Farb, A.; Guagliumi, G.; Kolodgie, F.D., 2004:
Drug-eluting stents: caution and concerns for long-term outcome

van der Hoeven, B.L.; Pires, N.M.M.; Warda, H.M.; Oemrawsingh, P.V.; van Vlijmen, B.J.M.; Quax, P.H.A.; Schalij, M.J.; van der Wall, E.E.; Jukema, J.Wouter., 2005:
Drug-eluting stents: results, promises and problems

Batista de Carvalho, L.A.E.; Marques, M.Paula.M.; Tomkinson, J., 2006:
Drug-excipient interactions in ketoprofen: a vibrational spectroscopy study

Goullé, J-Pierre.; Anger, J-Pierre., 2004:
Drug-facilitated robbery or sexual assault: problems associated with amnesia

Zhao, X.; You, T.; Liu, J.; Sun, X.; Yan, J.; Yang, X.; Wang, E., 2004:
Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection

Ueno, Y.; Futagawa, H.; Takagi, Y.; Ueno, A.; Mizushima, Y., 2005:
Drug-incorporating calcium carbonate nanoparticles for a new delivery system

Shah, R.R., 2005:
Drug-induced QT dispersion: does it predict the risk of torsade de pointes?

Shah, R.R., 2004:
Drug-induced QT interval prolongation: regulatory perspectives and drug development

Fenichel, R.R.; Malik, M.; Antzelevitch, C.; Sanguinetti, M.; Roden, D.M.; Priori, S.G.; Ruskin, J.N.; Lipicky, R.J.; Cantilena, L.R., 2004:
Drug-induced torsades de pointes and implications for drug development

Tokutomi, N.; Tokutomi, Y.; Nishi, K., 2004:
Drug-induced anomalous contraction of gastrointestinal tract of mice with impaired c-kit function

Izawa, M.; Harada, T.; Deura, I.; Taniguchi, F.; Iwabe, T.; Terakawa, N., 2005:
Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells

Zeltser, D.; Justo, D.; Halkin, A.; Rosso, R.; Ish-Shalom, M.; Hochenberg, M.; Viskin, S., 2004:
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug

Layland, L.E.; Wulferink, M.; Dierkes, S.; Gleichmann, E., 2004:
Drug-induced autoantibody formation in mice: triggering by primed CD4+CD25- T cells, prevention by primed CD4+CD25+ T cells

Calderone, V.; Testai, L.; Martinotti, E.; Del Tacca, M.; Breschi, M.Cristina., 2005:
Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics

Gussak, I.; Litwin, J.; Kleiman, R.; Grisanti, S.; Morganroth, J., 2004:
Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development

Pichon, M.F.; Cvitkovic, F.; Hacene, K.; Delaunay, J.; Lokiec, F.; Collignon, M.A.; Pecking, A.P., 2005:
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography

Mauz-Körholz, C.; Kachel, M.; Harms-Schirra, B.; Klein-Vehne, A.; Tunn, P-Ulrich.; Körholz, D., 2004:
Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells

Duggal, H.S.; Singh, I., 2005:
Drug-induced catatonia

Fujiki, A.; Sakabe, M.; Nishida, K.; Sugao, M.; Tsuneda, T.; Iwamoto, J.; Mizumaki, K.; Inoue, H., 2004:
Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine

Gerecitano, J.; Goy, A.; Wright, J.; MacGregor-Cortelli, B.; Neylon, E.; Gonen, M.; Esseltine, D.; Boral, A.; Schenkein, D.; Busam, K.; Teruya-Feldstein, J.; Sachs, D.; O'Connor, O.A., 2006:
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?

Zaprudnov, A.M., 2003:
Drug-induced damages to digestive organs in children

Patten, S.B.; Barbui, C., 2004:
Drug-induced depression: a systematic review to inform clinical practice

Tredwin, C.J.; Scully, C.; Bagan-Sebastian, J-V., 2005:
Drug-induced disorders of teeth

Yawalkar, N., 2005:
Drug-induced exanthems

Casetti, R.; Perretta, G.; Taglioni, A.; Mattei, M.; Colizzi, V.; Dieli, F.; D'Offizi, G.; Malkovsky, M.; Poccia, F., 2005:
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2

Martinez, J.M.; Sali, T.; Okazaki, R.; Anna, C.; Hollingshead, M.; Hose, C.; Monks, A.; Walker, N.J.; Baek, S.Joon.; Eling, T.E., 2006:
Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth

Hippius, M.; Hegenbart, U., 2005:
Drug-induced gastrointestinal disorders in surgical patients admitted to the University Hospital, Jena, Germany

Tomiyasu, N.; Tsuruta, O.; Mitsuyama, K.; Et-Al, 2005:
Drug-induced hemorrhagic enterocolitis

Tokumoto, Y.; Horiike, N.; Onji, M.; Ueda, T.; Kumagi, T.; Abe, M.; Michitaka, K., 2003:
Drug-induced hepatitis due to repeated use of hair dye

Grubisić-Cabo, F.; Vrdoljak, E., 2006:
Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy

Feenstra, J.; van Aken, M.O.; de Herder, W.W.; Feelders, R.A.; van der Lely, A.J., 2006:
Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant

Araujo, N.P.; Fukushiro, D.F.; Cunha, J.L.S.; Levin, R.; Chinen, C.C.; Carvalho, R.C.; Ribeiro, I.C.P.; Gomes, D.C.; Abílio, V.C.; Silva, R.H.; Ribeiro, R.de.A.; Frussa-Filho, R., 2006:
Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice

Bandyopadhyay, P., 2006:
Drug-induced hyperprolactinemia

Nakashima, H.; Yamane, K.; Ihn, H.; Nakamura, K.; Watanabe, R.; Kuwano, Y.; Takekoshi, T.; Watanabe, T.; Hattori, N.; Fujimoto, M.; Tamaki, K., 2005:
Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level

Hara, H.; Kobayashi, M.; Yokoyama, A.; Tochigi, M.; Matsunaga, A.; Shimizu, H.; Goshima, J.; Suzuki, H., 2005:
Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7

Mitani, N.; Aihara, M.; Yamakawa, Y.; Yamada, M.; Itoh, N.; Mizuki, N.; Ikezawa, Z., 2005:
Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses

Gaasbeek, D.; Naarding, P.; Stor, T.; Kremer, H.P.H., 2004:
Drug-induced hyperthermia in Huntington's disease

Aster, R.H., 2005:
Drug-induced immune cytopenias

Aquino, A.; Formica, V.; Prete, S.Pasquale.; Correale, P.Paolo.; Massara, M.Chiara.; Turriziani, M.; De Vecchis, L.; Bonmassar, E., 2004:
Drug-induced increase of carcinoembryonic antigen expression in cancer cells

Kamal, M.A.; French, S.W., 2004:
Drug-induced increased mitochondrial biogenesis in a liver biopsy

Arakawa, M.; Murata, Y.; Rikimaru, Y.; Sasaki, Y., 2005:
Drug-induced isolated visceral angioneurotic edema

Juurlink, D.N.; Mamdani, M.M.; Kopp, A.; Rochon, P.A.; Shulman, K.I.; Redelmeier, D.A., 2004:
Drug-induced lithium toxicity in the elderly: a population-based study

Sulkowski, M.S., 2004:
Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors

Dieterich, D.T.; Robinson, P.A.; Love, J.; Stern, J.O., 2004:
Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

Andrade, Rúl.J.; Lucena, M.Isabel.; Fernández, M.Carmen.; Pelaez, G.; Pachkoria, K.; García-Ruiz, E.; García-Muñoz, B.; González-Grande, R.; Pizarro, A.; Durán, Jé.Antonio.; Jiménez, M.; Rodrigo, L.; Romero-Gomez, M.; Navarro, Jé.María.; Planas, Rón.; Costa, J.; Borras, A.; Soler, A.; Salmerón, J.; Martin-Vivaldi, R., 2005:
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

Watkins, P.B.; Seeff, L.B., 2006:
Drug-induced liver injury: summary of a single topic clinical research conference